Professor Susan Tett is a registered pharmacist with research interests in Quality Use of Medicines (improving how medicines are used) and clinical pharmacokinetics (optimising medicine doses)
Sue completed her PhD in 1988. Since this time she has been in research positions and in academia at Sydney University, St Vincent’s Hospital, Sydney and at the University of Queensland. She has over 150 peer reviewed research publications and over 200 conference presentations and is on Editorial Board of Clinical Pharmacokinetics. Sue was Head of the School of Pharmacy, University of Queensland 1996-2004 and Deputy Executive Dean & Associate Dean Research for the Faculty of Health Sciences 2006-2010, including periods as Acting Executive Dean.
Susan Tett has been a member of many Australian national and State advisory committees, including Pharmaceutical Health and Rational use of Medicines Committee 1996-2004, Pharmaceutical Sub-Committee of the Australian Drug Evaluation Committee 1995-2004, Pharmaceutical Industry Working Group 2003-10 , Pharmaceutical Partnerships Program Committee of the Industry Research & Development Board 2003-09, and has participated in NHMRC Project Grant Review Panels and Fellowships Panels. She was also Councillor for the Pharmaceutical Society of Australia (Queensland Branch) and was the Australian Pharmacist of the Year in 1999, for her contributions to pharmacy education and research.
Sue’s research interests are directed towards optimising the clinical use of medications. General areas of research include quality use of medicines, clinical pharmacokinetics and pharmacodynamics. Sue supervises a number of postgraduate students and is actively involved in innovation in the pharmacy profession, pushing the professional boundaries. She is committed to enhancing the role of the health care team in optimising consumer health outcomes.
Journal Article: Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
Abd Rahman, Azrin N., Tett, Susan E. and Staatz, Christine E. (2013). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clinical Pharmacokinetics, 52 (5), 303-331. doi: 10.1007/s40262-013-0039-8
Journal Article: Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada
Tett, Susan E., Sketris, Ingrid, Cooke, Charmaine, Velhuyzen van Zanten, Sander and Barozzi, Nadia (2013). Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada. Pharmacoepidemiology and Drug Safety, 22 (7), 735-743. doi: 10.1002/pds.3442
Staatz, Christine E. and Tett, Susan E. (2011). Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?. Clinical Pharmacokinetics, 50 (12), 759-772. doi: 10.2165/11596380-000000000-00000
Journal Article: Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure
Tett, Susan E., Saint-Marcoux, Franck, Staatz, Christine E., Brunet, Merce, Vinks, Alexander A., Miura, Masatomo, Marquet, Pierre, Kuypers, Dirk R., van Gelder, Teun and Cattaneo, Dario (2011). Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplantation Reviews, 25 (2), 47-57. doi: 10.1016/j.trre.2010.06.001
Journal Article: How is medication prescribing ceased? A systematic review
Ostini, Remo, Jackson, Claire, Hegney, Desley and Tett, Susan E. (2011). How is medication prescribing ceased? A systematic review. Medical Care, 49 (1), 24-36. doi: 10.1097/MLR.0b013e3181ef9a7e
Journal Article: Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing
Barozzi, N. and Tett, S. E. (2009). Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing. Clinical Therapeutics, 31 (4), 849-861. doi: 10.1016/j.clinthera.2009.04.012
Journal Article: The Australian rise of esomeprazole-was expenditure on samples a contributor?
Kyle, G. J., Nissen, L. M. and Tett, S. E. (2009). The Australian rise of esomeprazole-was expenditure on samples a contributor?. Pharmacoepidemiology and Drug Safety, 18 (1), 62-68. doi: 10.1002/pds.1685
Ostini, R., Hegney, D., Mackson, J. M., Williamson, M and Tett, S.E. (2008). Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use. Pharmacoepidemiology and Drug Safety, 17 (11), 1077-1090. doi: 10.1002/pds.1638
Journal Article: A comparison of benzodiazepine and related drug use in Nova Scotia and Australia
Smith, Alesha J., Sketris, Ingrid, Cooke, Charmaine, Gardner, David, Kisely, Steve and Tett, Susan E. (2008). A comparison of benzodiazepine and related drug use in Nova Scotia and Australia. The Canadian Journal of Psychiatry, 53 (8), 545-552. doi: 10.1177/070674370805300809
(2014–2015) Churches of Christ in Queensland
Designing optimal dosing regimens for immunosuppressant medications
(2014) Queensland Pharmacy Research Trust
Utilisation review of Ezetimibe
(2013–2014) Department of Health and Ageing
(2009) Doctor Philosophy
(2008) Doctor Philosophy
CONVENTIONAL MEDICINE AND COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) - CONCORDANCE AND PERSPECTIVES OF CONSUMERS, HEALTH PROFESSIONALS AND CAM PRACTITIONERS
(2007) Doctor Philosophy
Towards optimal dosing of new immunosuppressant drugs in solid organ transplants
Improving dosing of immunosuppressant medications in people who have received solid organ transplants. Studies with tacrolimus, mycophenolate or sirolimus can be offered
International comparisons of medicines use, investigating pharmaceutical policy and other influences on usage
International comparisons of the use of prescription medicines are important to improve the quality use of medicines across different jurisdictions. Lessons learned from one area can be translated into interventions to be applied to improve medicine use across a number of different health care systems
Factors affecting prescribing and use of medicines, including the influence of various marketing strategies (eg. free prescription medicine samples), the influence of location (eg. rural, remote) and
Many factors are know to affect prescribing and use of medicines. Projects in this area will be designed to investigate specific aspects of these factors eg. effects of remote location, influence of free sample medications etc etc
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
Abd Rahman, Azrin N., Tett, Susan E. and Staatz, Christine E. (2013). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clinical Pharmacokinetics, 52 (5), 303-331. doi: 10.1007/s40262-013-0039-8
Tett, Susan E., Sketris, Ingrid, Cooke, Charmaine, Velhuyzen van Zanten, Sander and Barozzi, Nadia (2013). Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada. Pharmacoepidemiology and Drug Safety, 22 (7), 735-743. doi: 10.1002/pds.3442
Staatz, Christine E. and Tett, Susan E. (2011). Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?. Clinical Pharmacokinetics, 50 (12), 759-772. doi: 10.2165/11596380-000000000-00000
Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure
Tett, Susan E., Saint-Marcoux, Franck, Staatz, Christine E., Brunet, Merce, Vinks, Alexander A., Miura, Masatomo, Marquet, Pierre, Kuypers, Dirk R., van Gelder, Teun and Cattaneo, Dario (2011). Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplantation Reviews, 25 (2), 47-57. doi: 10.1016/j.trre.2010.06.001
How is medication prescribing ceased? A systematic review
Ostini, Remo, Jackson, Claire, Hegney, Desley and Tett, Susan E. (2011). How is medication prescribing ceased? A systematic review. Medical Care, 49 (1), 24-36. doi: 10.1097/MLR.0b013e3181ef9a7e
Barozzi, N. and Tett, S. E. (2009). Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing. Clinical Therapeutics, 31 (4), 849-861. doi: 10.1016/j.clinthera.2009.04.012
The Australian rise of esomeprazole-was expenditure on samples a contributor?
Kyle, G. J., Nissen, L. M. and Tett, S. E. (2009). The Australian rise of esomeprazole-was expenditure on samples a contributor?. Pharmacoepidemiology and Drug Safety, 18 (1), 62-68. doi: 10.1002/pds.1685
Ostini, R., Hegney, D., Mackson, J. M., Williamson, M and Tett, S.E. (2008). Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use. Pharmacoepidemiology and Drug Safety, 17 (11), 1077-1090. doi: 10.1002/pds.1638
A comparison of benzodiazepine and related drug use in Nova Scotia and Australia
Smith, Alesha J., Sketris, Ingrid, Cooke, Charmaine, Gardner, David, Kisely, Steve and Tett, Susan E. (2008). A comparison of benzodiazepine and related drug use in Nova Scotia and Australia. The Canadian Journal of Psychiatry, 53 (8), 545-552. doi: 10.1177/070674370805300809
Multicentre drug use evaluation in hospitals. QUM in hospitals: Queensland
Tett, Susan, Coombes, Judith and Pulver, Lisa (2011). Multicentre drug use evaluation in hospitals. QUM in hospitals: Queensland. St. Lucia, QLD, Australia: The University of Queensland.
Ostini, R., Roughead, E. E., Kirkpatrick, C. M. J., Monteith, G. and Tett, S. E. (2010). Quality use of medicines: the appropriateness of medicine naming and labelling; sound-alike, look-alike medicine names. Not available: National Medicines Policy Committee.
Discharge management of acute coronary syndromes project (DMACS) Queensland Arm
Tett, Susan, Coombes, Judith, Pulver, Lisa and Taylor, Donna (2009). Discharge management of acute coronary syndromes project (DMACS) Queensland Arm. St. Lucia, QLD Australia: The University of Queensland.
Understanding and improving prescribing practice
Ostini, Remo and Tett, Sue (2008). Understanding and improving prescribing practice. St Lucia, QLD Australia: UQ Blue Care Research & Practice Development Centre.
Multicentre drug use evaluation in hospitals: Acute Postoperative Pain Management Project APOP
Pulver, Lisa, Taylor, Donna, Tett, Susan E., Coombes, Judith and Petrie, Andrew (2008). Multicentre drug use evaluation in hospitals: Acute Postoperative Pain Management Project APOP. Not available:
Therapeutic drug monitoring in hematopoietic stem cell transplant recipients
Tran, H. and Tett, S. E. (2004). Therapeutic drug monitoring in hematopoietic stem cell transplant recipients. Clinical Bone Marrow and Blood Stem Cell Transplantation. (pp. 505-514) edited by K. Atkinson, W. E. Fibbe, R. Champlin, P. Ljungman, J. Ritz and M. K. Brenner. Cambridge, UK: Cambridge University Press.
Tett, S. E. (2001). Rheumatology. Clinical Pharmacy: A Practical Approach 2nd Edition. (pp. 341-350) edited by J. Hughes, R. Donnelly and G. James-Chatgilaou. Melbourne: Society of Hospital Pharmacists of Australia.
Therapeutic drug monitoring in hematopoietic stem cell transplant recipients
Tett, S. E (2000). Therapeutic drug monitoring in hematopoietic stem cell transplant recipients. Clinical Bone Marrow and Blood Stem Cell Transplantation. (pp. 193-200) edited by K. Atkinson. Cambridge, UK: Cambridge University Press.
Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2020). Evaluation of Bayesian forecasting methods for prediction of tacrolimus exposure using samples taken on two occasions in adult kidney transplant recipients. Therapeutic Drug Monitoring, 43 (2), 238-246. doi: 10.1097/ftd.0000000000000814
Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients. Clinical Drug Investigation, 39 (12), 1175-1184. doi: 10.1007/s40261-019-00844-y
Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients. Therapeutic Drug Monitoring, 41 (6), 755-760. doi: 10.1097/FTD.0000000000000687
Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2018). Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?. Drugs in R & D, 18 (4), 271-282. doi: 10.1007/s40268-018-0254-8
Jones, Mark, Tett, Susan E. and Del Mar, Chris (2018). Psychiatric adverse events in oseltamivir prophylaxis trials: novel comparative analysis using data obtained from clinical study reports. Pharmacoepidemiology and Drug Safety, 27 (11), 1217-1222. doi: 10.1002/pds.4651
Brooks, Emily K, Staatz, Christine E, Tett, Susan E, Isbel, Nicole M and McWhinney, Brett (2018). Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients. Therapeutic Drug Monitoring, 40 (2), 195-201. doi: 10.1097/FTD.0000000000000486
Abd Rahman, Azrin N, Tett, Susan E, Abdul Gafor, Halim A, McWhinney, Brett C and Staatz, Christine E (2017). Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis. European journal of drug metabolism and pharmacokinetics, 42 (6), 993-1004. doi: 10.1007/s13318-017-0420-3
Ezetimibe: use, costs, and adverse events in Australia
Hollingworth, Samantha A., Ostino, Remo, David, Michael C., Martin, Jennifer H. and Tett, Susan E. (2017). Ezetimibe: use, costs, and adverse events in Australia. Cardiovascular Therapeutics, 35 (1), 40-46. doi: 10.1111/1755-5922.12236
Jones, Mark, Tett, Susan, Peeters, Geeske M. E. E., Mishra, Gita D. and Dobson, Annette (2017). New-onset diabetes after statin exposure in elderly women: the Australian longitudinal study on women’s health. Drugs and Aging, 34 (3), 1-7. doi: 10.1007/s40266-017-0435-0
Peeters, Geeske, Tett, Susan E., Hollingworth, Samantha A., Gnjidic, Danijela, Hilmer, Sarah N., Dobson, Annette J. and Hubbard, Ruth E. (2016). Associations of guideline recommended medications for acute coronary syndromes with fall-related hospitalizations and cardiovascular events in older women with ischemic heart disease. Journals of Gerontology - Series A: Biological Sciences and Medical Sciences, 72 (2), 259-265. doi: 10.1093/gerona/glw111
Brooks, Emily, Tett, Susan E., Isbel, Nicole M. and Staatz, Christine E. (2016). Population pharmacokinetic modelling and bayesian estimation of tacrolimus exposure: is this clinically useful for dosage prediction yet?. Clinical Pharmacokinetics, 55 (11), 1295-1335. doi: 10.1007/s40262-016-0396-1
van Boheemen, Laurette, Tett, Susan E., Sohl, Evelien, Hugtenburg, Jacqueline G., van Schoor, Natasja M. and Peeters, G. M. E. E. (2016). Associations between statin use and physical function in older adults from the Netherlands and Australia: longitudinal aging study Amsterdam and Australian longitudinal study on women’s health. Drugs and Aging, 33 (6), 437-445. doi: 10.1007/s40266-016-0370-5
Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2016). Multinational evaluation of mycophenolic acid, tacrolimus, cyclosporin, sirolimus, and everolimus utilization. Annals of Transplantation, 21, 1-11. doi: 10.12659/AOT.895664
van der Hoorn, Mariëlle M. C., Tett, Susan E., de Vries, Oscar J., Dobson, Annette J. and Peeters, G. M. E. E. G. (Geeske) (2015). The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study. Bone, 81, 675-682. doi: 10.1016/j.bone.2015.08.024
Barozzi, Nadia, Peeters, GMEE Geeske and Tett, Susan E. (2015). Actions following adverse drug events – how do these influence uptake and utilisation of newer and/or similar medications. BMC Health Services Research, 15 (498) 498, 498. doi: 10.1186/s12913-015-1165-9
Abd Rahman, Azrin N., Tett, Susan E., Abdul Gafor, Halim A., Mcwhinney, Brett C. and Staatz, Christine E. (2015). Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis. British Journal of Clinical Pharmacology, 80 (5), 1064-1075. doi: 10.1111/bcp.12678
Clinical pharmacokinetics of once-daily tacrolimus in solid-organ transplant patients
Staatz, Christine E. and Tett, Susan E. (2015). Clinical pharmacokinetics of once-daily tacrolimus in solid-organ transplant patients. Clinical Pharmacokinetics, 54 (10), 993-1025. doi: 10.1007/s40262-015-0282-2
Peeters, Geeske, Tett, Susan E., Conaghan, Philip G., Mishra, Gita D. and Dobson, Annette J. (2015). Is statin use associated with new joint-related symptoms, physical function and quality of life? The Australian Longitudinal Study on Women’s Health. Arthritis Care and Research, 67 (1), 13-20. doi: 10.1002/acr.22389
Peeters, Geeske, Tett, Susan E., Duncan, Emma L., Mishra, Gita D. and Dobson, Annette J. (2014). Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy. Pharmacoepidemiology and Drug Safety, Early View (12), 1303-1311. doi: 10.1002/pds.3703
Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update
Staatz, Christine E. and Tett, Susan E. (2014). Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Archives of Toxicology, 88 (7), 1351-1389. doi: 10.1007/s00204-014-1247-1
Abd Rahman, Azrin N., Tett, Susan E. and Staatz, Christine E. (2014). How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?. Clinical Pharmacokinetics, 53 (3), 227-245-227-245. doi: 10.1007/s40262-013-0124-z
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
Abd Rahman, Azrin N., Tett, Susan E. and Staatz, Christine E. (2013). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clinical Pharmacokinetics, 52 (5), 303-331. doi: 10.1007/s40262-013-0039-8
Safety evaluation of leflunomide in rheumatoid arthritis
Keen, Helen I., Conaghan, Philip G. and Tett, Susan E. (2013). Safety evaluation of leflunomide in rheumatoid arthritis. Expert Opinion Drug Safety Evaluation, 12 (4), 581-588. doi: 10.1517/14740338.2013.798299
Tett, Susan E., Sketris, Ingrid, Cooke, Charmaine, Velhuyzen van Zanten, Sander and Barozzi, Nadia (2013). Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada. Pharmacoepidemiology and Drug Safety, 22 (7), 735-743. doi: 10.1002/pds.3442
Validity of self-reported osteoporosis in mid-age and older women
Peeters, G. M. E. E., Tett, Susan E., Dobson, A. J. and Mishra, G. D. (2013). Validity of self-reported osteoporosis in mid-age and older women. Osteoporosis International, 24 (3), 917-927. doi: 10.1007/s00198-012-2033-7
Carmichael, S. J., Day, R. O. and Tett, S. E. (2013). A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus. Internal Medicine Journal, 43 (5), 547-553. doi: 10.1111/imj.12100
Ostini, Remo, Roughead, Elizabeth E., Kirkpatrick, Carl M. J., Monteith, Gregory R. and Tett, Susan E. (2012). Quality use of medicines – Medication safety issues in naming; Look-alike, sound-alike medicine names. International Journal of Pharmacy Practice, 20 (6), 349-357. doi: 10.1111/j.2042-7174.2012.00210.x
Pulver, Lisa K., Oliver, Kate and Tett, Susan E. (2012). Innovation in hospital quality improvement activities — Acute Postoperative Pain Management (APOP) self-help toolkit audits as an example. Journal for Healthcare Quality, 34 (4), 45-59. doi: 10.1111/j.1945-1474.2012.00207.x.
Emmerton, Lynne, Fejzic, Jasmina and Tett, Susan E. (2012). Consumers' experiences and values in conventional and alternative medicine paradigms: A problem detection study (PDS). Bmc Complementary and Alternative Medicine, 12 (1) 39, 39-1-39-10. doi: 10.1186/1472-6882-12-39
Knowing how to stop: Ceasing prescribing when the medicine is no longer required
Ostini, Remo, Hegney, Desley G., Jackson, Claire and Tett, Susan E. (2012). Knowing how to stop: Ceasing prescribing when the medicine is no longer required. Journal of Managed Care Pharmacy, 18 (1), 68-72. doi: 10.18553/jmcp.2012.18.1.68
Peterson, Gregory M., Thompson, Angus, Pulver, Lisa K., Robertson, Marion B., Brieger, David, Wai, Angela and Tett, Susan E. (2012). Management of acute coronary syndromes at hospital discharge: Do targeted educational interventions improve practice quality?. Journal for Healthcare Quality, 34 (1), 26-34. doi: 10.1111/j.1945-1474.2011.00137.x
Staatz, Christine E. and Tett, Susan E. (2011). Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?. Clinical Pharmacokinetics, 50 (12), 759-772. doi: 10.2165/11596380-000000000-00000
Patel, Kashyap, Roberts, Jason A., Lipman, Jeffrey, Tett, Susan E., Deldot, Megan E. and Kirkpatrick, Carl M. (2011). Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration - using Monte Carlo Simulations to predict doses for specified pharmacodynamic targets. Antimicrobial Agents and Chemotherapy, 55 (12), 5868-5873. doi: 10.1128/AAC.00424-11
Mcintosh, Kylie A., Maxwell, David J., Pulver, Lisa K., Horn, Fiona, Robertson, Marion B., Kaye, Karen I., Peterson, Gregory M., Dollman, William B., Wai, Angela and Tett, Susan E. (2011). A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments. International Journal for Quality in Health Care, 23 (2) mzq077, 142-150. doi: 10.1093/intqhc/mzq077
Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure
Tett, Susan E., Saint-Marcoux, Franck, Staatz, Christine E., Brunet, Merce, Vinks, Alexander A., Miura, Masatomo, Marquet, Pierre, Kuypers, Dirk R., van Gelder, Teun and Cattaneo, Dario (2011). Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplantation Reviews, 25 (2), 47-57. doi: 10.1016/j.trre.2010.06.001
How is medication prescribing ceased? A systematic review
Ostini, Remo, Jackson, Claire, Hegney, Desley and Tett, Susan E. (2011). How is medication prescribing ceased? A systematic review. Medical Care, 49 (1), 24-36. doi: 10.1097/MLR.0b013e3181ef9a7e
Kyle, GJ, Nissen, L and Tett, S (2010). Community pharmacy dispensing of prescription medicine sample packs: Changing the business of medicine initiation?. Journal of Evaluation in Clinical Practice, 16 (6), 1357-1360. doi: 10.1111/j.1365-2753.2009.01290.x
Smith, Alisha J. and Tett, Susan E. (2010). Improving the use of benzodiazepines-Is it possible? A non-systematic review of interventions tried in the last 20 years. BMC Health Services Research, 10 (1) 321, 321-1-321-12. doi: 10.1186/1472-6963-10-321
An intervention to improve benzodiazepine use-a new approach
Smith, Alesha and Tett, Susan E. (2010). An intervention to improve benzodiazepine use-a new approach. Family Practice, 27 (3), 320-327. doi: 10.1093/fampra/cmq007
Smith, A, Tett, S and Hall, W (2010). The contribution of injecting drug users in Sydney, Melbourne and Brisbane to rising benzodiazepine use in Australia 2000 to 2006. Australian And New Zealand Journal of Public Health, 34 (3), 315-319. doi: 10.1111/j.1753-6405.2010.00533.x
Fejzic, J., Emmerton, L. and Tett, S. E. (2010). Towards concordance in healthcare: Perspectives of general practitioners, complementary and alternative medicine practitioners and pharmacists in Australia. Journal of Clinical Pharmacy and Therapeutics, 35 (3), 309-321. doi: 10.1111/j.1365-2710.2009.01093.x
Staatz, Christine E., Goodman, Lucy K. and Tett, Susan E. (2010). Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II. Clinical Pharmacokinetics, 49 (4), 207-221. doi: 10.2165/11317550-000000000-00000
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation
Kuypers, Dirk R. J., Le Meur, Yannick, Cantarovich, Marcel, Tredger, Michael J., Tett, Susan E., Cattaneo, Dario, Tonshoff, Burkhard, Holt, David W., Chapman, Jeremy, van Gelder, Teun, for The Transplantation Society (TTS) Consensus Group on TDM of MPA and Staatz, Christine E. (2010). Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. Clinical Journal of the American Society of Nephrology, 5 (2), 341-358. doi: 10.2215/CJN.07111009
Staatz, Christine E., Goodman, Lucy K. and Tett, Susan E. (2010). Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Clinical Pharmacokinetics, 49 (3), 141-175. doi: 10.2165/11317350-000000000-00000
Pulver, Lisa K., Tett, Susan E. and Coombes, Judith (2009). The Queensland experience of participation in a national drug use evaluation project - Community-Acquired Pneumonia-Towards Improving Outcomes Nationally (CAPTION). BMC Pulmonary Medicine, 9 (1) 38, 1-6. doi: 10.1186/1471-2466-9-38
Barozzi, Nadia, Sketris, Ingrid, Cooke, Charmaine and Tett, Susan (2009). Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2)inhibitors use in Australia and Nova Scotia (Canada). British Journal of Clinical Pharmacology, 68 (1), 106-115. doi: 10.1111/j.1365-2125.2009.03410.x
Staatz, Christine E., Smith, Alesha J. and Tett, Susan E. (2009). A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme. Pharmacoepidemiology and drug safety, 18 (5), 386-392. doi: 10.1002/pds.1726
Smith, Alesha and Tett, Sue E. (2009). How Do Different Age Groups Use Benzodiazepines and Antidepressants?: Analysis of an Australian Administrative Database, 2003–6. Drugs & Aging, 26 (2), 113-122. doi: 10.2165/0002512-200926020-00003
Barozzi, N. and Tett, S. E. (2009). Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing. Clinical Therapeutics, 31 (4), 849-861. doi: 10.1016/j.clinthera.2009.04.012
Barozzi, N. and Tett, S. E. (2009). Perceived barriers to paracetamol (acetaminophen)prescribing, especially following rofecoxib withdrawal from the market. Clinical Rheumatology, 28 (5), 509-519. doi: 10.1007/s10067-008-1077-8
Systematic review of interventions to improve prescribing
Ostini, Remo, Hegney, Desley, Jackson, Claire, Williamson, Margaret, Mackson, Judith M., Gurman, Karin, Hall, Wayne and Tett, Susan E. (2009). Systematic review of interventions to improve prescribing. The Annals of Pharmacotherapy, 43 (3), 502-513. doi: 10.1345/aph.1L488
The Australian rise of esomeprazole-was expenditure on samples a contributor?
Kyle, G. J., Nissen, L. M. and Tett, S. E. (2009). The Australian rise of esomeprazole-was expenditure on samples a contributor?. Pharmacoepidemiology and Drug Safety, 18 (1), 62-68. doi: 10.1002/pds.1685
Ostini, R., Hegney, D., Mackson, J. M., Williamson, M and Tett, S.E. (2008). Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use. Pharmacoepidemiology and Drug Safety, 17 (11), 1077-1090. doi: 10.1002/pds.1638
Kyle, G. J., Nissen, L. M. and Tett, S. E. (2008). Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines. Journal of Clinical Pharmacy and Therapeutics, 33 (5), 553-559. doi: 10.1111/j.1365-2710.2008.00948.x
Barozzi, Nardia and Tett, Susan E. (2008). Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia. BMC Health Services Research, 8 (Article Number: 196) 196, 196-1-196-9. doi: 10.1186/1472-6963-8-196
A comparison of benzodiazepine and related drug use in Nova Scotia and Australia
Smith, Alesha J., Sketris, Ingrid, Cooke, Charmaine, Gardner, David, Kisely, Steve and Tett, Susan E. (2008). A comparison of benzodiazepine and related drug use in Nova Scotia and Australia. The Canadian Journal of Psychiatry, 53 (8), 545-552. doi: 10.1177/070674370805300809
A comparison of antidepressant use in Nova Scotia, Canada and Australia
Smith, Alesha J., Sketris, Ingrid, Cook, Charmaine, Gardner, David, Kisely, Steve and Tett, Susan E. (2008). A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiology and Drug Safety, 17 (7), 697-706. doi: 10.1002/pds.1541
Clinical pharmacology: Opportunities for educating new practitioners: An Australian perspective
Tett, S. E. (2008). Clinical pharmacology: Opportunities for educating new practitioners: An Australian perspective. Clinical Pharmacology & Therapeutics, 83 (6), 921-924. doi: 10.1038/clpt.2008.49
Roos, J. F., Kirkpatrick, C. M. J., Tett, S. E., MaLachlan, A. J. and Duffull, S. B. (2008). Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infection. British Journal of Clinical Pharmacology, 66 (4), 455-466. doi: 10.1111/j.1365-2125.2008.03247.x
Kyle, G. J., Nissen, L. M. and Tett, S. E. (2008). Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews. Clinical Therapeutics, 30 (12), 2461-2473. doi: 10.1016/j.clinthera.2008.12.016
Roos, J. F., Doust, J., Tett, S. E. and Kirkpatrick, C. M. J. (2007). Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children- A meta-analysis. Clinical Biochemistry, 40 (5-6), 383-391. doi: 10.1016/j.clinbiochem.2006.10.026
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients
Staatz, Christine E. and Tett, Susan E. (2007). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clinical Pharmacokinetics, 46 (1), 13-58. doi: 10.2165/00003088-200746010-00002
Barozzi, N. and Tett, S. E. (2007). Cox-2 inhibitor influence on non-steroidal antiinflammatory drug (NSAIDs) and paracetamol use in 6 countries. Pharmacoepidemiology And Drug Safety, 16 (s2), S80-S80. doi: 10.1002/pds.1461
Barozzi, N. and Tett, S. E. (2007). What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?. Pharmacoepidemiology and Drug Safety, 16 (11), 1184-1191. doi: 10.1002/pds.1451
Perceptions of the influence of prescription medicine samples on prescribing by family physicians
Hall, Kristine B., Tett, Susan E. and Nissen, Lisa M. (2006). Perceptions of the influence of prescription medicine samples on prescribing by family physicians. Medical Care, 44 (4), 383-387. doi: 10.1097/01.mlr.0000204017.71426.53
Drug utilization review across jurisdictions – a reality or still a distant dream?
Pulver, Lisa K. and Tett, Susan E. (2006). Drug utilization review across jurisdictions – a reality or still a distant dream?. European Journal of Clinical Pharmacology, 62 (2), 97-106. doi: 10.1007/s00228-005-0087-6
A Bayesian approach for population pharmacokinetic modelling of sirolimus
Dansirikul, Chantaratsamon, Morris, Raymond G., Tett, Susan E. and Duffull, Stephen B. (2006). A Bayesian approach for population pharmacokinetic modelling of sirolimus. British Journal of Clinical Pharmacology, 62 (4), 420-434. doi: 10.1111/j.1365-2125.2005.02533.x
Changes in use of disease-modifying anti-rheumatic drugs in Australia over the period 1992-2004
Chan, V. and Tett, S. E. (2006). Changes in use of disease-modifying anti-rheumatic drugs in Australia over the period 1992-2004. Pharmacoepidemiology And Drug Safety, 15 (7), 462-468. doi: 10.1002/pds.1256
Chan, V. and Tett, S. E. (2006). How is leflunomide prescribed and used in Australia? analysis of prescribing and adverse effect reporting. Pharmacoepidemiology And Drug Safety, 15 (7), 485-493. doi: 10.1002/pds.1252
Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2006). Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients. Journal of Clinical Pharmacy And Therapeutics, 31 (1), 17-25. doi: 10.1111/j.1365-2710.2006.00697.x
Consumer involvement in quality use of medicines (QUM) projects - lessons from Australia
Kirkpatrick, Carl M. J., Roughead, Elizabeth E., Monteith, Gregory R. and Tett, Susan E. (2005). Consumer involvement in quality use of medicines (QUM) projects - lessons from Australia. BMC Health Services Research, 5 (1) 75, 75.1-75.7. doi: 10.1186/1472-6963-5-75
Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation
Staatz, Christine E., Duffull, Stephen B., Kiberd, Bryce, Fraser, Albert D. and Tett, Susan E. (2005). Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. European Journal of Clinical Pharmacology, 61 (7), 507-516. doi: 10.1007/s00228-005-0927-4
Cooke, C., Nissen, L. M., Sketris, I. S. and Tett, S. E. (2005). Quantifying the use of the statin antilipemic drugs: Comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia. Clinical Therapeutics, 27 (4), 497-508. doi: 10.1016/j.clinthera.2005.04.009
Cutts, C. and Tett, S.E. (2005). Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural Australia. Australian Journal of Rural Health, 13 (1), 43-50. doi: 10.1111/j.1440-1854.2004.00644.x
Empiric management of community-acquired pneumonia in Australian emergency departments
Maxwell, D. J., McIntosh, K. A., Pulver, L. K., Easton, K. L., CAPTION Study Grp and Tett, S. E. (2005). Empiric management of community-acquired pneumonia in Australian emergency departments. Medical Journal of Australia, 183 (10), 520-524. doi: 10.5694/j.1326-5377.2005.tb07153.x
Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period
Kiberd, B., Puthenparumpil, J. J., Fraser, A., Tett, S. E. and Lawen, J. (2005). Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period. Transplantation Proceedings, 37 (5), 2320-2323. doi: 10.1016/j.transproceed.2005.03.059
Behan, K., Cutts, C. and Tett, S. E. (2005). Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitors. Journal of Clinical Pharmacy And Therapeutics, 30 (4), 337-343. doi: 10.1111/j.1365-2710.2005.00648.x
Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant
Atcheson, Bronwyn A., Taylor, Paul J., Mudge, David W., Johnson, David W., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Pillans, Peter I. and Tett, Susan E. (2005). Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. British Journal of Clinical Pharmacology, 59 (3), 271-280. doi: 10.1111/j.1365-2125.2004.02235.x
Pharmacokinetic considerations relating to tacrolimus dosing in the elderly
Staatz, C. E. and Tett, S. E. (2005). Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs & Aging, 22 (7), 541-557. doi: 10.2165/00002512-200522070-00001
Chan, V., Charles, B. G. and Tett, S. E. (2005). Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis. British Journal of Clinical Pharmacology, 60 (3), 257-264. doi: 10.1111/j.1365-2125.2005.02415.x
Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients
Dansirikul, C., Duffull, S. B., Morris, R. G. and Tett, S. E. (2005). Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients. British Journal of Clinical Pharmacology, 60 (5), 560-565. doi: 10.1111/j.1365-2125.2005.02473.x
Behan, K., Cutts, C. and Tett, S. E. (2005). Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors. European Journal of Clinical Pharmacology, 61 (1), 55-58. doi: 10.1007/s00228-004-0865-6
Bajramovic, Jasmina, Emmerton, Lynne and Tett, Susan E. (2004). Perceptions around concordance - focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expectations, 7 (3), 221-234. doi: 10.1111/j.1369-7625.2004.00280.x
DelDot, Megan E., Lipman, Jeffrey and Tett, Susan E. (2004). Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration. British Journal of Clinical Pharmacology, 58 (3), 259-268. doi: 10.1111/j.1365-2125.2004.02143.x
Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia
Atcheson, Bronwyn A., Taylor, Paul J., Kirkpatrick, Carl M. J., Duffull, Stephen B., Mudge, David W., Pillans, Peter I., Johnson, David W. and Tett, Susan E. (2004). Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Therapeutic Drug Monitoring, 26 (3), 284-286. doi: 10.1097/00007691-200406000-00011
A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation
Staatz, Christine E., Taylor, Paul J., Lynch, Stephen V. and Tett, Susan E. (2004). A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Liver Transplantation, 10 (4), 506-512. doi: 10.1002/lt.20065
A perspective on Australia's national medicines policy
Tett, S. E. (2004). A perspective on Australia's national medicines policy. Canadian Journal of Clinical Pharmacology, 11 (1), e28-e38. doi: 10.22374/jptcp.v11i1.62
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
Staatz, C. E. and Tett, S. E. (2004). Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clinical Pharmacokinetics, 43 (10), 623-653. doi: 10.2165/00003088-200443100-00001
Medication management reviews for people from the former Yugoslavia now resident in Australia
Bajramovic Fejzic, J. and Tett, S. E. (2004). Medication management reviews for people from the former Yugoslavia now resident in Australia. Pharmacy World and Science, 26 (5), 271-276. doi: 10.1023/B:PHAR.0000042879.89551.70
Atcheson, Bronwyn, Taylor, Paul J., Mudge, David W., Johnson, David W., Pillans, Peter I. and Tett, Susan E. (2004). Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection. Journal of Chromatography B, 799 (1), 157-163. doi: 10.1016/j.jchromb.2003.10.033
Chan, V., Charles, B. G. and Tett, S. E. (2004). Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography. Journal of Chromatography B-analytical Technologies In The Biomedical And Life Sciences, 803 (2), 331-335. doi: 10.1016/j.jchromb.2004.01.016
Sampling times for monitoring tacrolimus in stable adult liver transplant recipients
Dansirikul, C, Staatz, CE, Duffull, SB, Taylor, PJ, Lynch, SV and Tett, SE (2004). Sampling times for monitoring tacrolimus in stable adult liver transplant recipients. Therapeutic Drug Monitoring, 26 (6), 593-599. doi: 10.1097/00007691-200412000-00003
Willis, Charlene, Staatz, Christine E. and Tett, Susan E. (2003). Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients. Therapeutic Drug Monitoring, 25 (2), 158-166. doi: 10.1097/00007691-200304000-00004
Tett, S. E. (2003). Across the dividing range - bridging the divides: Pharmacy opportunities across the hospital/community and inter-professional divides in rural and remote Australia. Journal of Pharmacy Practice and Research, 33 (3), 172-172. doi: 10.1002/jppr2003333172
Cutts, C., La Caze, A. and Tett, S.E. (2003). Audit of selective and non-selective non-steroidal anti-inflammatory drug use in rural general practice. Journal of Pharmacy Practice and Research, 33 (1), 70-73. doi: 10.1002/jppr200333170
Cutts, Christopher and Tett, Susan E. (2003). Doctors perceptions of the influences on their prescribing: a comparison of general practitioners based in rural and urban Australia. European Journal of Clinical Pharmacology, 58 (11), 761-766. doi: 10.1007/s00228-002-0551-5
Influences on doctors' prescribing: Is geographical remoteness a factor?
Cutts, C. and Tett, S. E. (2003). Influences on doctors' prescribing: Is geographical remoteness a factor?. Australian Journal of Rural Health, 11 (3), 124-130. doi: 10.1046/j.1440-1584.2003.00502.x
Atcheson, B., Taylor, P. J., Pillans, P. I. and Tett, S. E. (2003). Measurement of free drug and clinical end-point by high-performance liquid chromatography-mass spectrometry: Applications and implications for pharmacokinetic and pharmacodynamic studies. Analytica Chimica Acta, 492 (2003), 157-169. doi: 10.1016/S0003-2670(03)00359-3
Shum, B, Duffull, SB, Taylor, PJ and Tett, SE (2003). Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil. British Journal of Clinical Pharmacology, 56 (2003), 188-197. doi: 10.1046/j.1365-2125.2003.01863.x
Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis
Carmichael, S. J., Charles, B. and Tett, S. E. (2003). Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis. Therapeutic Drug Monitoring, 25 (6), 671-681. doi: 10.1097/00007691-200312000-00005
Groves, K. E. M., Sketris, I. and Tett, S. E. (2003). Prescription drug samples: Does this marketing strategy counteract policies for quality use of medicines?. Journal of Clinical Pharmacy And Therapeutics, 28 (4), 259-271. doi: 10.1046/j.1365-2710.2003.00481.x
Principles and clinical application of assessing alterations in renal elimination pathways
Tett, Susan E., Kirkpatrick, Carl M. J., Gross, Annette S. and McLachlan, Andrew J. (2003). Principles and clinical application of assessing alterations in renal elimination pathways. Clinical Pharmacokinetics, 42 (14), 1193-1211. doi: 10.2165/00003088-200342140-00002
Staatz, Christine E., Willis, Charlene, Taylor, Paul J, Lynch, Stephen V. and Tett, Susan E. (2003). Toward better outcomes with tacrolimus therapy: Population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Liver Transplantation, 9 (2), 130-137. doi: 10.1053/jlts.2003.50023
Wade, A. H., Weir, D. N., Cameron, A. P. and Tett, S. E. (2003). Using a problem detection study (PDS) to identify and compare health care provider and consumer views of antihypertensive therapy. Journal of Human Hypertension, 17 (17), 397-405. doi: 10.1038/sj.jhh.1001565
Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus
Staatz, Christine E. and Tett, Susan E. (2002). Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus. European Journal of Clinical Pharmacology, 58 (9), 597-605. doi: 10.1007/s00228-002-0517-7
Cyclosporin monitoring in Australasia: 2002 update of consensus guidelines
Morris, Raymond G., Ilett, Kenneth F., Tett, Susan E., Ray, John E., Fullinfaw, Robert O., Cooke, Russell and Cook, Stephen (2002). Cyclosporin monitoring in Australasia: 2002 update of consensus guidelines. Therapeutic Drug Monitoring, 24 (6), 677-688. doi: 10.1097/00007691-200212000-00001
Community pharmacists improving health outcomes in rural and remote Queensland
Nissen, L. M. and Tett, S.E. (2002). Community pharmacists improving health outcomes in rural and remote Queensland. Australian Pharmacist, 21 (11), 874-880.
Carmichael, S. J., Beal, J., Day, R. O. and Tett, S. E. (2002). Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate. Journal of Rheumatology, 29 (10), 2077-2083.
Staatz, C. E., Taylor, P. J. and Tett, S. E. (2002). Comparison of an ELISA and an LC/MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients. Therapeutic Drug Monitoring, 24 (5), 607-615. doi: 10.1097/01.FTD.0000028922.76397.78
Evaluating Australia's National Medicines Policy using geographical mapping
Roughead, E. E., Monteith, G. R., Harvey, K. J. and Tett, S. E. (2002). Evaluating Australia's National Medicines Policy using geographical mapping. Internal Medicine Journal, 32 (3), 66-71. doi: 10.1046/j.1445-5994.2002.00166.x
A clinical audit of the prescribing of celecoxib and rofecoxib in Australian rural general practice
Cutts, C., La Caze, A. and Tett, S. E. (2002). A clinical audit of the prescribing of celecoxib and rofecoxib in Australian rural general practice. British Journal of Clinical Pharmacology, 54 (5), 522-527. doi: 10.1046/j.1365-2125.2002.01666.x
Change and stability in the Canadian healthcare system: Meeting report CHERA 2002
Brown, M. G., Hicks, V. and Tett, S. E (2002). Change and stability in the Canadian healthcare system: Meeting report CHERA 2002. Expert Review of Pharmacoeconomics & Outcomes Research, 2 (4), 309-312. doi: 10.1586/14737167.2.4.309
Population pharmacokinetics of tacrolimus in adult kidney transplant recipients
Staatz, C. E., Willis, C., Taylor, P. J. and Tett, S. E. (2002). Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Clinical Pharmacology & Therapeutics, 72 (6), 660-669. doi: 10.1067/mcp.2002.129304
The use of ACE-inhibitors after myocardial infarction
Overland, V., Cottrell, N. and Tett, S. E. (2002). The use of ACE-inhibitors after myocardial infarction. Journal of Pharmacy Practice & Research, 32 (3), 232-234. doi: 10.1002/jppr2002323232
Tett, S.E. (2002). Wintering in Nova Scotia. Australian Pharmacist, 21 (7), 478-480.
Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants
Staatz, Christine E., Taylor, Paul J., Lynch, Stephen V., Willis, Charlene, Charles, Bruce G. and Tett, Susan E. (2001). Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants. Transplantation, 72 (6), 1056-1061. doi: 10.1097/00007890-200109270-00013
Pillans, Peter I., Rigby, Russell J., Kubler, Paul, Willis, Charlene, Salm, Paul, Tett, Susan E. and Taylor, Paul J. (2001). A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients. Clinical Biochemistry, 34 (1), 77-81. doi: 10.1016/S0009-9120(00)00196-X
Accurate estimation of mycophenolic acid AUC
Taylor, P. J., Willis, C., Salm, P., Tett, S. E. and Pillans, P. I. (2001). Accurate estimation of mycophenolic acid AUC. Therapeutic Drug Monitoring, 23 (3), 301-302. doi: 10.1097/00007691-200106000-00021
McLachlan, AJ, Gross, AS, Beal, JL, Minns, I and Tett, SE (2001). Analytical validation for a series of marker compounds used to assess renal drug elimination processes. Therapeutic Drug Monitoring, 23 (1), 39-46. doi: 10.1097/00007691-200102000-00008
Concepts for critical appraisal of an original research paper.
Duffull, S. B. and Tett, S. E. (2001). Concepts for critical appraisal of an original research paper.. Australian Journal of Hospital Pharmacy, 31 (3), 200-205.
Drug use evaluation of ipratropium bromide at two tertiary referral hospitals in Brisbane.
Cardiff, L. M., Coombes, J., Matthews, J., Poulier, M. V. and Tett, S.E. (2001). Drug use evaluation of ipratropium bromide at two tertiary referral hospitals in Brisbane.. Australian Journal of Hospital Pharmacy, 31 (4), 279-283. doi: 10.1002/jppr2001314279
Staatz, C, Taylor, P and Tett, S (2001). Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation. Nephrology Dialysis Transplantation, 16 (9), 1905-1909. doi: 10.1093/ndt/16.9.1905
Nissen, L. M., Tett, S. E., Cramond, T., Williams, B. and Smith, M. T. (2001). Opioid analgesic prescribing and use - an audit of analgesic prescribing by general practitioners and The Multidisciplinary Pain Centre at Royal Brisbane Hospital. British Journal of Clinical Pharmacology, 52 (6), 693-698. doi: 10.1046/j.0306-5251.2001.01502.x
Population pharmacokinetics of lamotrigine
Chan, V., Morris, R. G., Ilett, K. F. and Tett, S. E. (2001). Population pharmacokinetics of lamotrigine. Therapeutic Drug Monitoring, 23 (6), 630-635. doi: 10.1097/00007691-200112000-00006
Gross, AS, McLachlan, AJ, Minns, I, Beal, JB and Tett, SE (2001). Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol. British Journal of Clinical Pharmacology, 51 (6), 547-555. doi: 10.1046/j.1365-2125.2001.01390.x
Willis, C., Taylor, P. J., Salm, P., Tett, S. E. and Pillans, P. I. (2000). Quantification of free mycophenolic acid by high-performance liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry. Journal of Chromatography B, 748 (1), 151-156. doi: 10.1016/S0378-4347(00)00273-5
Tett, S. E., Cutler, D. J., Beck, C. and Day, R. O. (2000). Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis - A prospective, dose ranging study. Journal of Rheumatology, 27 (7), 1656-1660.
Willis, C., Taylor, P. J., Salm, P., Tett, S. E. and Pillans, P. I. (2000). Evaluation of limited sampling strategies for estimation of 12-hour mycophenolic acid area under the plasma concentration-time curve in adult renal transplant patients. Therapeutic Drug Monitoring, 22 (5), 549-554. doi: 10.1097/00007691-200010000-00008
Problems of pharmacy communication in multicultural Australia
Bajramovic, J. and Tett, S. E (2000). Problems of pharmacy communication in multicultural Australia. Australian Pharmacist, 19 (7), 430-434.
Quality use of medicines: Onwards up the pyramid
Tett, S. E. and Roughead, E. E. (2000). Quality use of medicines: Onwards up the pyramid. The Australian Journal of Hospital Pharmacy, 30 (5), 191-192. doi: 10.1002/jppr2000305191
An Australian PharmD: Doctor of Clinical Pharmacy, University of Queensland
Pulver, L. K. and Tett, S. E. (1999). An Australian PharmD: Doctor of Clinical Pharmacy, University of Queensland. Australian Journal of Hospital Pharmacy, 29 (5), 284-286. doi: 10.1002/jppr1999295284
McCrudden, E. A. and Tett, S. E. (1999). Improved high-performance liquid chromatography determination of methotrexate and its major metabolite in plasma using a poly(styrene-divinylbenzene) column. Journal of Chromatography B-analytical Technologies In The Biomedical And Life Sciences, 721 (1), 87-92. doi: 10.1016/S0378-4347(98)00439-3
Therapeutic drug monitoring and clinical toxicology - Opportunities not to be missed
Tett, S. E. (1999). Therapeutic drug monitoring and clinical toxicology - Opportunities not to be missed. Australian Journal of Hospital Pharmacy, 29 (2), 82-83. doi: 10.1002/jppr199929282a
Beal, J. L. and Tett, S. E. (1998). Determination of pindolol enantiomers in human plasma and urine by simple liquid-liquid extraction and high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 715 (2), 409-415. doi: 10.1016/S0378-4347(98)00260-6
Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approach
McLachlan, A. J. and Tett, S. E. (1998). Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approach. Therapeutic Drug Monitoring, 20 (4), 390-395. doi: 10.1097/00007691-199808000-00007
Beal, J. L., Jones, C. E., Taylor, P. J. and Tett, S. E. (1998). Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay. Therapeutic Drug Monitoring, 20 (6), 685-690. doi: 10.1097/00007691-199812000-00019
Population pharmacokinetics and pharmacodynamics: An underutilized resource
Tett, S. E., Holford, N. H. and McLachlan, A. J. (1998). Population pharmacokinetics and pharmacodynamics: An underutilized resource. Drug Information Journal, 32 (3), 693-710. doi: 10.1177/009286159803200310
Pharmacokinetics of fluconazole in people with HIV infection: A population analysis
McLachlan, AJ and Tett, SE (1996). Pharmacokinetics of fluconazole in people with HIV infection: A population analysis. British Journal of Clinical Pharmacology, 41 (4), 291-298. doi: 10.1046/j.1365-2125.1996.03085.x
Hydroxychloroquine relative bioavailability: Within subject reproducibility
Tett, S, Day, R and Cutler, D (1996). Hydroxychloroquine relative bioavailability: Within subject reproducibility. British Journal of Clinical Pharmacology, 41 (3), 244-246. doi: 10.1111/j.1365-2125.1996.tb00190.x
Use of methotrexate in older patients - A risk-benefit assessment
Tett, SE and Triggs, EJ (1996). Use of methotrexate in older patients - A risk-benefit assessment. Drugs & Aging, 9 (6), 458-471. doi: 10.2165/00002512-199609060-00008
Tett, S, Moore, S and Ray, J (1995). Pharmacokinetics and Bioavailability of Fluconazole in 2 Groups of Males with Human-Immunodeficiency-Virus (hiv) Infection Compared with Those in a Group of Males Without Hiv-Infection. Antimicrobial Agents and Chemotherapy, 39 (8), 1835-1841.
Adverse Drug-Reactions and Their Measurement in the Rheumatic Diseases
Day, RO, Quinn, DI, Conaghan, PG and Tett, SE (1995). Adverse Drug-Reactions and Their Measurement in the Rheumatic Diseases. Journal of Rheumatology, 22 (5), 983-988.
Cyclosporine-A Monitoring in Australia - Consensus Recommendations
Morris, RG, Tett, SE and Ray, JE (1994). Cyclosporine-A Monitoring in Australia - Consensus Recommendations. Therapeutic Drug Monitoring, 16 (6), 570-576. doi: 10.1097/00007691-199412000-00007
Randall, Ctc and Tett, SE (1994). Phenytoin Pharmacokinetics After Intravenous Administration to Patients Receiving Enteral Tube-Feeding. Pharmacy World & Science, 16 (5), 217-224. doi: 10.1007/BF01871260
Bioavailability of Hydroxychloroquine Tablets in Patients with Rheumatoid-Arthritis
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1994). Bioavailability of Hydroxychloroquine Tablets in Patients with Rheumatoid-Arthritis. British Journal of Rheumatology, 33 (3), 235-239.
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1993). Absorption and In-Vivo Dissolution of Hydroxycholoroquine in Fed Subjects Assessed Using Deconvolution Techniques. British Journal of Clinical Pharmacology, 36 (5), 405-411. doi: 10.1111/j.1365-2125.1993.tb00388.x
Clinical Pharmacokinetics of Slow-Acting Antirheumatic Drugs
Tett, SE (1993). Clinical Pharmacokinetics of Slow-Acting Antirheumatic Drugs. Clinical Pharmacokinetics, 25 (5), 392-407. doi: 10.2165/00003088-199325050-00005
Tett, SE, Day, RO and Cutler, DJ (1993). Concentration-Effect Relationship of Hydroxychloroquine in Rheumatoid-Arthritis - a Cross-Sectional Study. Journal of Rheumatology, 20 (11), 1874-1879.
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1993). Disposition of the Enantiomers of Hydroxychloroquine in Patients with Rheumatoid-Arthritis Following Multiple Doses of the Racemate. British Journal of Clinical Pharmacology, 36 (1), 78-81. doi: 10.1111/j.1365-2125.1993.tb05897.x
Plasma-Protein Binding of the Enantiomers of Hydroxychloroquine and Metabolites
McLachlan, AJ, Cutler, DJ and Tett, SE (1993). Plasma-Protein Binding of the Enantiomers of Hydroxychloroquine and Metabolites. European Journal of Clinical Pharmacology, 44 (5), 481-484. doi: 10.1007/BF00315548
Tett, S, Espinos, E and Weekes, L (1993). Who Is Ordering All Those Cyclosporine Concentrations and How Do They Use Them - An Audit of Cyclosporine Therapeutic Drug-Monitoring. Therapeutic Drug Monitoring, 15 (3), 195-198. doi: 10.1097/00007691-199306000-00003
Interpretation of Chloroquine Pharmacokinetic Data
McLachlan, A, Tett, S, Day, R and Cutler, D (1993). Interpretation of Chloroquine Pharmacokinetic Data. European Journal of Clinical Pharmacology, 44 (4), 407-408. doi: 10.1007/BF00316484
Tett, SE, Higgins, GM and Armour, CL (1993). Impact of Pharmacist Interventions On Medication Management by the Elderly - a Review of the Literature. Annals of Pharmacotherapy, 27 (1), 80-86. doi: 10.1177/106002809302700118
Simons, LA, Tett, S, Simons, J, Lauchlan, R, McCallum, J, Friedlander, Y and Powell, I (1992). Multiple Medication Use in the Elderly - Use of Prescription and Nonprescription Drugs in An Australian Community Setting. Medical Journal of Australia, 157 (4), 242-&.
Drug-Interactions with Fluconazole
Tett, S and Lee, HS (1992). Drug-Interactions with Fluconazole. Medical Journal of Australia, 156 (5), 365-365.
Bioavailability of Hydroxychloroquine Tablets Assessed with Deconvolution Techniques
Tett, SE, Cutler, DJ and Day, RO (1992). Bioavailability of Hydroxychloroquine Tablets Assessed with Deconvolution Techniques. Journal of Pharmaceutical Sciences, 81 (2), 155-159. doi: 10.1002/jps.2600810211
McLachlan, AJ, Tett, SE and Cutler, DJ (1991). High-Performance Liquid-Chromatographic Separation of the Enantiomers of Hydroxychloroquine and its Major Metabolites in Biological-Fluids Using An Alpha-1-Acid Glycoprotein Stationary Phase. Journal of Chromatography-Biomedical Applications, 570 (1), 119-127. doi: 10.1016/0378-4347(91)80206-R
Antimalarials in Rheumatic Diseases
Tett, S, Cutler, D and Day, R (1990). Antimalarials in Rheumatic Diseases. Baillieres Clinical Rheumatology, 4 (3), 467-489. doi: 10.1016/S0950-3579(05)80004-4
Bioavailability of Hydroxychloroquine Tablets in Healthy-Volunteers
Tett, SE, Cutler, DJ, Day, RO and Brown, KF (1989). Bioavailability of Hydroxychloroquine Tablets in Healthy-Volunteers. British Journal of Clinical Pharmacology, 27 (6), 771-779. doi: 10.1111/j.1365-2125.1989.tb03439.x
Tett, SE, Cutler, DJ, Day, RO and Brown, KF (1988). A Dose-Ranging Study of the Pharmacokinetics of Hydroxychloroquine Following Intravenous Administration to Healthy-Volunteers. British Journal of Clinical Pharmacology, 26 (3), 303-313. doi: 10.1111/j.1365-2125.1988.tb05281.x
Tett, SE and Cutler, DJ (1987). Apparent Dose-Dependence of Chloroquine Pharmacokinetics Due to Limited Assay Sensitivity and Short Sampling Times. European Journal of Clinical Pharmacology, 31 (6), 729-731. doi: 10.1007/BF00541305
Tett, SE, Cutler, DJ and Brown, KF (1986). Removal of An Endogenous Fluorescent Compound From Urine to Allow Quantitation of Low Concentrations of Hydroxychloroquine and Metabolites by High-Performance Liquid-Chromatography. Journal of Chromatography, 383 (1), 236-238. doi: 10.1016/S0378-4347(00)83468-4
Tett, SE, Cutler, DJ and Brown, KF (1985). High-Performance Liquid-Chromatographic Assay for Hydroxychloroquine and Metabolites in Blood and Plasma, Using a Stationary Phase of Poly(styrene Divinylbenzene) and a Mobile Phase At Ph 11, with Fluorimetric Detection. Journal of Chromatography, 344 (NOV), 241-248. doi: 10.1016/S0378-4347(00)82024-1
Saliva prednisolone measurements in adult kidney transplant recipients
Staatz, C. E., Tett, S. E., Isbel, N., Mc Whinney, B. and Brooks, E. (2019). Saliva prednisolone measurements in adult kidney transplant recipients. International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Foz de Iguassu, Brazil, September 2019.
Brooks, E., Tett, S. E., Isbel, N. M., McWhinney, B. and Staatz, C. E. (2018). Evaluation of multiple linear regression limited sampling strategies for enteric-coated mycophenolate sodium in adult kidney transplant recipients.. American Transplant Congress, Seattle, WA United States, 2-6 June 2018. Hoboken, NJ United States: Wiley.
Brooks, E., Tett, S. E., Isbel, N. M., McWhinney, B. and Staatz, C. E. (2018). Saliva mycophenolic acid monitoring following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients.. International Association of Therapeutic Drug Monitoring and Clinical Toxicology Brisbane, Brisbane, QLD Australia, 16-19 September 2018.
Brooks, E., Tett, S. E., Isbel, N. and Staatz, C. E. (2018). Saliva prednisolone in adult kidney transplant recipients receiving triple therapy with tacrolimus, mycophenolate sodium and prednisolone. RACP Trainee Research Awards, Brisbane, QLD Australia, 7 November 2018.
Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2016). Evolving Australian, and Northern European, Utilisation Patterns for Immunosuppressants After Transplantation. HOBOKEN: WILEY-BLACKWELL.
Gardiner, K. M., Tett, S. E. and Staatz, C. E. (2015). Evolving utilisation patterns in Australia of immunosuppressants after transplantation including comparison to Northern European countries. APSA-ASCEPT Joint Scientific Meeting 2015, Hobart, Australia, 29 November-2 December 2015.
Abd Rahman, Nurul Azrin, Tett, Suszn E., Abdul Gafor, Abdul Halim, McWhinney, Brett D. and Staatz, Christine E. (2015). Pharmacokinetic modelling of enterohepatic circulation of mycophenolic acid in Malaysian lupus nephritis patients. Population Approach Group in Australia and New Zealand conference, Melbourne, Australia, January 16, 2015.
Proton Pump Inhibitors-Should More Care Be Taken with Prescribing for Older Women?
Tett, Susan E., van der Hoorn, Marielle M. C., Dobson, Annette J. and Peeters, Geeske G. M. E. E. (2015). Proton Pump Inhibitors-Should More Care Be Taken with Prescribing for Older Women?. International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Boston, MA, United States, 22-26 August 2015. HOBOKEN: WILEY-BLACKWELL. doi: 10.1002/pds.3838
Staatz, C. E., Gardiner, K. M. and Tett, S. E. (2014). Comparing utilisation of mycophenolate, tacrolimus, cyclosporin, sirolimus and everolimus in Australia and Northern Europe. Joint meeting of ASCEPT and Molecular Pharmacology of G protein-coupled receptors (MGPPCR), Melbourne, Australia, 7-11th December 2014.
Hollingworth, Samantha A., Ostini, Remo, Michael, David, Martin, Jennifer and Susan, Tett (2014). Use of Ezetimibe in Australia. 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Taipei, Taiwan, 24–27 October 2014. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/pds.3701
Abu Rahman, A. N., Tett, S. E. and Staatz, C. E. (2013). A review of population pharmacokinetic and pharmacodynamic studies of mycophenolate in Autoimmune Disease patients. Population Approach Group in Australia and New Zealand conference, Brisbane, QLD, Australia, February 2013.
Peeters, G., Tett, S. E., Duncan, E. L., Mishra, G. D. and Dobson, A. J. (2013). Patterns of Osteoporosis Medication Dispensing for Older Australian Women From 2002 to 2010: Influences of Publications, Guidelines, Marketing Activities and Policy. EULAR 2013, Madrid, Spain, 12 - 15 June 2013. London, United Kingdom: B M J Group. doi: 10.1136/annrheumdis-2013-eular.908
Differences in gastroprotective medication use between Australia and Nova Scotia, Canada
Tett, Susan E., Sketris, Ingrid, Cooke, Charmaine, van Zanten, Sander Veldhuyzen and Barozzi, Nadia (2012). Differences in gastroprotective medication use between Australia and Nova Scotia, Canada. 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Barcelona, Spain, 23-26 August 2012. West Sussex, United Kingdom: John Wiley and Sons. doi: 10.1002/pds.3324
The discharge management of acute coronary syndromes (DMACS) toolkit experience
Pulver, Lisa, Oliver, Kate and Tett, Susan (2012). The discharge management of acute coronary syndromes (DMACS) toolkit experience. National Medicines Symposium 2012, Sydney, Australia, 24-25 May 2012.
Smith, Alesha, Pulver, Lisa, Coombes, Judith and Tett, Susan E. (2012). Visualising communication networks to improve use of medicines in elderly residents across care sites. National Medicines Symposium 2012, Sydneay, Australia, 24-25 May 2012.
Knowing how to stop: Prescription medicines and the culture of giving
Tett, Susan E., Ostini, Remo, Hegney, Desley G. and Jackson, C (2011). Knowing how to stop: Prescription medicines and the culture of giving. Canadian Association for Health Services and Policy Research (CAHSPR), Halifax, Canada, 9-12 May 2011.
Pulver, Lisa, Tett, Susan E. and Oliver, K (2011). Sustainability in hospital quality improvement activities - the Acute PostOperative Pain management (APOP) toolkit experience. Medicines Management 2011, the 37th SHPA National Conference, Hobart, Australia, 10-13 November 2011.
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation
Kuypers, Dirk R. J., Le Meur, Yannick, Cantarovich, Marcelo, Tredger, Michael J., Tett, Susan E., Cattaneo, Dario, Tönshoff, Burkhard, Holt, David W., Chapman, Jeremy and Van Gelder, Teun (2010). Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. doi: 10.2215/CJN.07111009
Kyle, Greg, Nissen, L. M. and Tett, S. E. (2009). Community pharmacy dispensing of prescription medicine sample packs: Changing the business of medicine initiation?. ISPOR 12th Annual European Congress, Paris, France, 24-27 October 2009. Malden, MA, U.S.A.: Blackwell Science. doi: 10.1016/S1098-3015(10)74694-5
The acute postoperative pain (APOP) project: An Australian quality improvement initiative
McIntosh, K. A., Wai, A., Mackson, J. M., Robertson, M. B., Maxwell, D. J., Kaye, K. I., Pulver, L. K., Taylor, D., Tett, S. E., Tompson, A., Peterson, G. M., Reeves, A., Loh, S. F. and Weekes, L. (2009). The acute postoperative pain (APOP) project: An Australian quality improvement initiative. 26th International Conference: The International Society for Quality in Health Care. Dublin 2009: Designing for Quality, Dublin, Ireland, 11-14 October 2009.
Choosing an intervention to reduce the use of benzodiazepine and related compounds in Australia
Smith, Alesha J. and Tett, Susan E. (2008). Choosing an intervention to reduce the use of benzodiazepine and related compounds in Australia. ISPE 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Copenhagen, Denmark, 17 - 20 August 2008. Chichester, West Sussex, U. K.: John Wiley & Sons. doi: 10.1002/pds.1631
Comparisons of mycophenolate usage in Northern European and Australian transplant populations
Smith, Alesha, Staatz, Christine E. and Tett, Susan E. (2008). Comparisons of mycophenolate usage in Northern European and Australian transplant populations. 9th World Conference on Clinical Pharmacology and Therapeutics, Quebec, Canada, 27 July - 1 August 2008. Oakville, ON, Canada: Pulsus Group.
Brooks, E. K., Johnson, D. W., Staatz, Christine E., Taylor, P. J. and Tett, Susan E. (2008). Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation. Australian Health and Medical Research Congress (AHMRC) 2008, Brisbane, Australia, 16-21 November 2008. Sydney, Australia: AHMRC.
Involvement in a national multicentre DUE: An evaluation by participating Queensland hospitals
Coombes, J. A., Pulver, L. K., Taylor, D. R. and Tett, S. E. (2008). Involvement in a national multicentre DUE: An evaluation by participating Queensland hospitals. 2008 National Medicines Symposium, Canberra, Australia, 14-16 May 2008.
Kisely, Steve, Smith, Alesha, Sketris, Ingrid, Cooke, Charmaine, Gardner, David and Tett, Sue (2008). Is there an association between the range of benzodiazepines available and the quality of prescribing?: An international comparison of Canada and Australia using administrative data. Annual Scientific Meeting of the Canadian Academy of Psychiatric Epidemiology, Vancouver, Canada, 4 September 2008.
Optimising acute postoperative pain management: Making a difference
Wai, A., Mackson, J. M., Kaye, K. I., Maxwell, D. J., McIntosh, K. A., Robertson, M. B., Tompson, A., Loh, S. F., Reeves, A., Pulver, L. K., Taylor, D. and Tett, S. E. (2008). Optimising acute postoperative pain management: Making a difference. 6th Australasian Conference on Safety and Quality in Health Care, Christchurch, NZ, 1-3 September 2008.
Wai, A., Maxwell, D., Kaye, K., McIntosh, K., Robertson, M., Tompson, A., Peterson, G., Reeves, A., Pulver, L., Tett, S. and Mackson, J. (2008). Optimising hospital management of acute postoperative pain: A national quality improvement initiative. National Medicines Symposium, Canberra, Australia, 14-16 May 2008.
Pattern of mycophenolate prescribing in Australian kidney and cardiac transplant recipients
Staatz, Christine E., Smith, Alesha and Tett, Susan E. (2008). Pattern of mycophenolate prescribing in Australian kidney and cardiac transplant recipients. National Medicines Symposium 2008, Canberra, 14-16 May 2008.
Taking academic detailing to hospitals: The APOP experience
Pulver, L. K., Taylor, D. R., Tett, S. E., Rowett, D. and Wai, A. (2008). Taking academic detailing to hospitals: The APOP experience. National Medicines Symposium 2008, Canberra, Australia, 14-16 May 2008.
A comparison of benzodiazepine and related drug use in Nova Scotia, Canada and Australia
Tett, S. E., Smith, A. J., Sketris, I., Cooke, C., Gardner, D. and Kisely, S. A. (2007). A comparison of benzodiazepine and related drug use in Nova Scotia, Canada and Australia. 4th Canadian Therapeutics Congress, Halifax, Canada, 27-30 May, 2007. Hamilton, Canada: Canadian Society of Pharmacology and Therapeutics.
Analgesic use and communication at discharge in postoperative patients: APOP initiative.
Wai, A., McIntosh, K. A., Robertson, M., Reeves, A., Pulver, L. K., Tett, S. E., Maxwell, D. J., Kaye, K. I., Tompson, A., Peterson, G. A. and Loukas, K. (2007). Analgesic use and communication at discharge in postoperative patients: APOP initiative.. SHPA 28th Federal Conference 2007, Convention Centre, Sydney Australia, 8 - 11 November 2007.
Concordance in conventional and complementary paradigms: A problem-detection study
Feizic, J., Emmerton, L. and Tett, S. (2007). Concordance in conventional and complementary paradigms: A problem-detection study. Annual Conference of the Australasian Pharmaceutical Science Association, Sydney, NSW, Australia, 8 - 11 December, 2007. Australian Pharmaceutical Science Association.
Roos, J. F., Tett, S. E., Kirkpatrick, C. M. J. and Duffull, S. B. (2007). Development of a sufficient design for parameter estimation of fluconazole population pharmacokinetics in HIV patients. PAGANZ 07: Population Approach Group in Australia & New Zealand, Singapore, 13-15 February 2007. Population Approach Group in Australia and New Zealand.
Kyle, G., Tett, S. and Nissen, L. (2007). Doctor, Pharmacist and Consumer Perceptions of Prescription Medicine Sample Packs – Present and Future. Australasian Pharmaceutical Science Association Annual Conference, Manly, Sydney, 8-11 December 2007. Australasian Pharmaceutical Science Association.
Kisely, Steve, Smith, Alesha, Cooke, Charmaine, Tett, Susan, Sketris, Ingrid and Gardner, David (2007). Is there an association between the range of benzodiazepines available and the quality of prescribing? An international comparison. 23rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Quebec, Canada, 19- 22 August 2007. CHICHESTER: John Wiley & Sons. doi: 10.1002/pds.1461
Kisely, Steve, Smith, Alesha, Cooke, Charmaine, Tett, Susan, Sketris, Ingrid and Gardner, David (2007). Is there an association between the range of benzodiazepines available and the quality of prescribing? An international comparison. 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Quebec City, Canada, 19 - 22 August 2007. UK: Bell and Bain Ltd..
Staatz, Christine, Wong, Jenny, Taylor, Paul, Johnson, David and Tett, Susan (2007). Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period. 10th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Nice, France, 9-14 September, 2007. New York: Lippincott-Raven. doi: 10.1097/FTD.0b013e31813797e8
Pain Assessment - Not Just A Score
Pulver, L., Taylor, D. and Tett, S. (2007). Pain Assessment - Not Just A Score. SHPA 28th Federal Conference 2007, Convention Centre, Sydney Australia, 8 - 11 November 2007.
Barozzi, N. and Tett, S.E. (2007). Perceived barriers to acetaminophen prescribing, especially following rofecoxib withdrawal from the market. 4th Canadian Therapeutics Congress, Halifax, Nova Scotia, Canada, 27-30 May 2007. Canada: Pulsus Group Inc.
Kyle, Greg, Tett, Susan and Nissen, Lisa (2007). Prescription Medicine Sample Packs: How Are they Viewed By Professional, Government, Industry and Consumer Organisations?. Annual Conference Of The Australasian Pharmaceutical Science Association, Manly Pacific, Sydney, 8-11 December 2007.
The Australian rise of Esomeprazole - Is expenditure on samples a contributor?
Kyle, Greg, Nissen, Lisa and Tett, Sue (2007). The Australian rise of Esomeprazole - Is expenditure on samples a contributor?. 23rd International Conference on Pharmacoepidemiology and Drug Safety, Quebec City Canada, 19-22 August, 2007. UK: Bell and Bain Ltd.. doi: 10.1002/pds.1461
Maxwell, D., Kaye, K. I., McIntosh, K., Robertson, M. B., Stanton, L .A., Peterson, G. M., Marwood, A. C., Dollman, W. B., Pulver, L., Tett, S. E., Coombes, J., Petrie, A. F., Wai, A., Horn, F., Mackson, J. and Weekes, L. M. (2006). Community-acquired pneumonia: Towards improving outcomes nationally. A national quality improvement initiative 'Down Under'. The 23rd International Conference of the International Society for Quality in Health Care, London / QE11 Centre, 22-25 October 2006. UK: ISQua.
Evaluating how guidelines for replacement therapy were implemented following withdrawal of rofecoxib
Barozzi, N. and Tett, S. E. (2006). Evaluating how guidelines for replacement therapy were implemented following withdrawal of rofecoxib. The National Institute of Clinical Studies Using Evidence: Using, Melbourne, 19-20 October 2006. Melbourne: National Institute of Clinical Studies.
Coulson, F. R. and Tett, S. E. (2006). Geographical differences in antidepressant and benzodiazepine prescribing in rural and urban Queensland. Quality use of medicines: Balancing beliefs, benefits and harms, National Convention Centre, Canberrra, 7-9 June 2006. Brisbane: National Prescribing Service.
Barozzi, N. and Tett, S. E. (2006). How did rofecoxib withdrawal influence overall non-steroidal anti-inflammatory drug (NSAIDs) and paracetamol prescribing in Australia?. Quality Use of Medicines: Balancing Beliefs, Benefits and Harms, Canberra / National Convention Centre, 7-9 June 2006. Canberra: National Prescribing Service Limited.
Maxwell, D. J., Kaye, K. I., MacIntosh, K. A., Robertson, M. B., Stanton, L. A., Peterson, G. M., Marwood, A. C., Dollman, W. B., Pulver, L., Tett, S. E., Wai, A. and Mackson, J. (2006). Influencing emergency department prescribing in the management of community acquired pneumonia - the CAPTION project. Australian Society for Antimicrobials 7th Annual Scientific Meeting, Sydney / Crowne Plaza, Coogee Beach, 23-25 February 2006. Sydney: Australian Society for Antimicrobials.
National quality improvement initiatives - CAPTION and beyond
Wai, A., Horn, F., Mackson, J. M., Maxwell, D. J., Kaye, K. I., McIntosh, K. A., Robertson, M. B., Stanton, L. A., Peterson, G. M., Marwood, A. C., Dollman, W. B., Pulver, L. K., Tett, S. E., Coombes, J., Petrie, A. and Weekes, L. (2006). National quality improvement initiatives - CAPTION and beyond. 4th Australasian Conference on Safety and Quality in Health Care, Melbourne, Australia, 21st - 23rd August, 2006.
Barozzi, N. and Tett, S. E. (2006). Non-steroidal anti-inflammatory drug prescription in relation to the prescribing of gastroprotective drugs in Australia. 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Lisbon, Portugal, 24-27 August 2006. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/pds.1295
Revamped, redeveloped, relaunched...the new QUMmap
Tett, S. E., Roughead, E. E., Monteith, G. R. and Kirkpatrick, C. M. J. (2006). Revamped, redeveloped, relaunched...the new QUMmap. Quality use of medicines: Balancing beliefs, benefits and harms, National Convention Centre, Canberrra, Australia, 7-9 June, 2006. Brisbane, Qld, Australia: National Prescribing Service.
Spin-offs and bonanzas from Queensland participating in CAPTION
Pulver, L., Coombes, J., Petrie, A. F. and Tett, S. E. (2006). Spin-offs and bonanzas from Queensland participating in CAPTION. Quality Use of Medicines: Balancing Beliefs, Benefits and Harms, Canberra / National Convention Centre, 7-9 June 2006. Canberra: National Prescribing Service Limited.
Tinkering with the immune system - When, why and how for optimal therapeutics
Tett, S. E. (2006). Tinkering with the immune system - When, why and how for optimal therapeutics. Canadian Therapeutics Congress, Toronto, Canada, May 2006. Canada: Canadian Association of Population therapeutics; Canadian Society for Clinical Pharmacology.
Consumers on the map: Australia's QUM map
Tett, S. E., Roughead, E. E., Monteith, G. R. and Kirkpatrick, C. M. J. (2005). Consumers on the map: Australia's QUM map. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, Qld, Australia, 10-13 November, 2005. Brisbane, Qld, Australia: Event Planners Australia.
Cystatin C to estimate renal function: A meta-analysis
Roos, J. F., Doust, J., Tett, S.E. and Kirkpatrick, C. M. J. (2005). Cystatin C to estimate renal function: A meta-analysis. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.
Directions for pharmacy as we move forward
Tett, S. E. (2005). Directions for pharmacy as we move forward. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia.
Drug utilisation review across jurisdictions: A reality or still a distant dream?
Pulver, L. and Tett, S.E. (2005). Drug utilisation review across jurisdictions: A reality or still a distant dream?. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia.
How much, how often, how long?
Tett, S. E. (2005). How much, how often, how long?. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.
Behan, K., Cutts, C. and Tett, S. E. (2005). Influences on the prescribing of new drugs in rural and urban Queensland: The example of COX-2 inhibitors. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia.
Population pharmacokinetics: A way forward for optimal dosage prediction in children
Tett, S. E. (2005). Population pharmacokinetics: A way forward for optimal dosage prediction in children. 10th International Congress of Pediatric Laboratory Medicine, Singapore, 3-6 Sept. 2005. Singapore: IAPLM.
Barozzi, N. and Tett, S.E. (2005). Use of non-selective non-steroidal anti-inflammatory drugs (NSAID), COX-2 inhibitors (COX-2) and paracetamol. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.
An argument for dose individualisation of sirolimus in renal transplant recipients
Dansirikul, C., Duffull, S. B., Morris, R. and Tett, S.E. (2004). An argument for dose individualisation of sirolimus in renal transplant recipients. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.v31_i11_abs.x
Bayesian population pharmacokinetic analysis of sirolimus
Dansirikul, C., Friberg, L. E., Duffull, S. B., Morris, R. and Tett, S.E. (2004). Bayesian population pharmacokinetic analysis of sirolimus. Population Approach Group in Europe - Thirteenth Meeting (PAGE), Uppsala University, Sweden, 17-18 June 2004. Sweden: Uppsala University.
Sketris, I., Cooke, C., Nissen, L. M. and Tett, S.E (2004). Cross country comparisons of drug utilisation: Experiences with an Australian and Canadian 'statin' comparison. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service.
Do prescription medicine samples influence prescribing? Issues in Australian general practice
Hall, K. H., Tett, S. E. and Nissen, L. M. (2004). Do prescription medicine samples influence prescribing? Issues in Australian general practice. Annual Conference of the APSA, 2004, Melbourne, Vic, Australia, 4-7 December, 2004. Mount Waverley, Victoria: Australasian Pharmaceutical Science Association.
Dose adjustment in renal impairment: A community approach
Manning, M. J., Tett, S. E. and Kirkpatrick, C. M. J. (2004). Dose adjustment in renal impairment: A community approach. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service.
Chan, V. and Tett, S. E. (2004). How is leflunomide prescribed and used in Australia? Analysis of prescribing, usage and adverse effect reporting. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service.
Is cystatin-C a marker of renal function?
Roos, J. F., Kirkpatrick, C. M. J. and Tett, S. E. (2004). Is cystatin-C a marker of renal function?. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x
Bajramovic Fejzic, J., Emmerton, L. M. and Tett, S. E. (2004). Perceptions of concordance with medicines: Focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. 13th International Social Pharmacy Workshop, Malta, 19-23 July, 2004. Malta: Malta College of Pharmacy Practice.
Tett, S. E., Atcheson, B. A., Taylor, P. J., Johnson, D. W., Mudge, D. W. and Pillans, P. I. (2004). Pharmacokinetics and pharmacodynamics of mycophenolic acid and its glucuronide early after renal transplantation. 8th World Conference on Clinical Pharmacology & Therapeutics 2004, Brisbane, Australia, 1-6 August, 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x
Population pharmacokinetic and pharmacodynamic analysis of leflunomide in rheumatoid arthritis
Chan, V., Charles, B. G. and Tett, S. E. (2004). Population pharmacokinetic and pharmacodynamic analysis of leflunomide in rheumatoid arthritis. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x
Nissen, L. M., Cooke, C., Sketris, I. and Tett, S.E. (2004). Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, Australia. CPT2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing. doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x
Sample medication: What do Australian general practitioners think?
Nissen, L. M., Hall, K. H. and Tett, S. E. (2004). Sample medication: What do Australian general practitioners think?. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service.
Working with health professionals and consumers in tandem: What is the evidence?
Tett, S.E (2004). Working with health professionals and consumers in tandem: What is the evidence?. National Medicines Symposium 2004, Brisbane, 28-30 July 2004. Sydney: National Prescribing Service.
Analysis of free mycophenolic acid and its glucuronide in human blood samples
Atcheson, B., Taylor, P. J. and Tett, S. E. (2003). Analysis of free mycophenolic acid and its glucuronide in human blood samples. IATDMCT Congress, Basel, Switzerland, September 2003. New York , U. S.:
Analysis of free mycophenolic acid and its glucuronide in human blood samples
Atcheson, B. A., Taylor, P. J. and Tett, S. E. (2003). Analysis of free mycophenolic acid and its glucuronide in human blood samples. International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Basel, Switzerland, 7-11 September, 2003. Switzerland:
Can telepharmacy provide pharmacy services in the bush?
Nissen, L. M. and Tett, S.E. (2003). Can telepharmacy provide pharmacy services in the bush?. 3rd International Conference on Successes and Failures in Telehealth 2003, Brisbane, 25-26 August, 2003. London: Royal Society of Medicine Press. doi: 10.1258/135763303322596228
Detecting drug interactions associated with tacrolimus
Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Detecting drug interactions associated with tacrolimus. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:
Cooke, C., Tett, S.E and Sketris, I. (2003). Five year trends in HMG co-A reductase inhibitor use in Nova Scotia, Canada and Queensland, Australia. Annual Conference of the Canadian Association for Population Therapeutics 2003, Quebec, 30 Mar. - 1 Apr. 2003. Canada: Pulsus.
Implementing a community pharmacy care integration project in rural Australia
Nissen, L. M. and Tett, S. E. (2003). Implementing a community pharmacy care integration project in rural Australia. Annual Conference of the Canadian Association for Population Therapeutics 2003, Quebec, 30 March - 1 April 2003. Canada: Pulsus.
Limited sampling strategies for monitoring tacrolimus in liver transplant recipients
Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2003). Limited sampling strategies for monitoring tacrolimus in liver transplant recipients. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:
Pattern of disease modifying anti-rheumatic drug utilisation in Australia 1992-2002
Chan, V. and Tett, S.E. (2003). Pattern of disease modifying anti-rheumatic drug utilisation in Australia 1992-2002. Annual Conference of APSA 2003, Bondi Beach, NSW, 3-5 Dec. 2003. Sydney: APSA.
Pharmacodynamic investigations of tacrolimus in liver transplantation
Staatz, C. E., Dansirikul, C., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S. E. (2003). Pharmacodynamic investigations of tacrolimus in liver transplantation. TSANZ 21st Annual Scientific Meeting, Canberra, 9-11 April 2003. Canberra: TSANZ. doi: 10.1046/j.1440-1711.2003.00812.x
Pharmacodynamics of tacrolimus in pediatric liver transplantation
Staatz, C. E., TaylorPJ, LynchSV, TettSE, SSoldin and FSjoeqvist (2003). Pharmacodynamics of tacrolimus in pediatric liver transplantation. 8th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Basel, Switzerland, 7-11 September, 2003. New York: Lippincott-Raven.
Power calculation for a study with multivariate outcomes
Kirkpatrick, C. M. J., Duffull, S. B. and Tett, S. E. (2003). Power calculation for a study with multivariate outcomes. 5th Annual PAWS & PAGANZ Scientific Meeting, Sydney, Aust., 19-21 Feb. 2003. Sydney:
Cutts, C., La Caze, A., Rees, K., Behan, K., Punchard, H., Lum, E. P. M., Lees, J., Hutchinson, J. and Tett, S. E. (2002). A locally delivered integrated Quality Use of Medicine program for rural general practitioners and other health professionals in rural Queensland. National Medicines Symposium 2002, Canberra, 20-22 March 2002. Canberra: NPS.
A pharmacodynamic investigation of tacrolimus in paediatric liver transplant recipients
Staatz, C. E., Taylor, P. J., Lynch, S. V., Willis, C. and Tett, S.E. (2002). A pharmacodynamic investigation of tacrolimus in paediatric liver transplant recipients. AHMRC 2002, Melbourne, 24-29 Nov. 2002. Melbourne: NHMRC.
Abbreviated AUC for monitoring tacrolimus in liver transplant recipients
Dansirikul, C., Staatz, C. E., Duffull, S. B., Taylor, P. J., Lynch, S. V. and Tett, S.E. (2002). Abbreviated AUC for monitoring tacrolimus in liver transplant recipients. AHMRC 2002, Melbourne, 24-29 Nov. 2002. Melbourne: NHMRC.
Nissen, L. M. and Tett, S. E. (2002). Community pharmacists improving patient health outcomes: A new model of care for rural and remote Queensland. Queensland Health & Medical Scientific Meeting, Brisbane, 4-5 Dec. 2002. Brisbane: Qld. Health.
Ensuring a bold new future for Pharmacy in the bush: Telepharmacy
Nissen, L. M., Tett, S.E., Kinsey, I., Cutts, C. and La Caze, A. (2002). Ensuring a bold new future for Pharmacy in the bush: Telepharmacy. 8th Pharmacy Australia Congress 2002, Hobart, 18-21 October 2002. Hobart: Pharmaceutical Society of Australia.
Experiential education research in the undergraduate pharmacy curricula
McKauge, L. M., Dall'Alba, G., Butler, J. E. and Tett, S. E. (2002). Experiential education research in the undergraduate pharmacy curricula. The Monash Pharmacy Practice Symposium 2002, Prato, Italy, 9-10 September,. 2002. Melbourne: Monash University.
Identification of influences on the Quality Use of Medicines in rural Australia
Cutts, C. and Tett, S. E. (2002). Identification of influences on the Quality Use of Medicines in rural Australia. National Medicines Symposium 2002, Canberra, 20-22 March 2002. Canberra: NPS.
Pharmacists integrating care for patients with complex needs in rural and remote Queensland
Nissen, L. M. and Tett, S. E. (2002). Pharmacists integrating care for patients with complex needs in rural and remote Queensland. The 5th Wonca World Conference on Rural Health, Melbourne, 30 Apr - 3 May 2002.
Chan, V., Charles, B. G. and Tett, S. E. (2002). Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography. Annual Conference of the Australasian Pharmaceutical Science Association, Melbourne, 8-11 Dec. 2002. Melbourne: APSA.
www.qummap.health.gov.au: What's happening where? Who's involved? What's missing?
Roughead, E. E., Monteith, G. R. and Tett, S.E. (2002). www.qummap.health.gov.au: What's happening where? Who's involved? What's missing?. National Medicines Symposium 2002, Canberra, 20-22 March 2002. Canberra: NPS.
A community pharmacy care integration project: Results of a study in rural and remote Queensland
Nissen, L., Emerson, L. and Tett, S. E. (2001). A community pharmacy care integration project: Results of a study in rural and remote Queensland. APSA Annual Conference 2001, Melbourne, 9-12 December 2001. Melbourne: Australasian Pharmaceutical Science Association.
Clinical pharmacy mentoring: Its role in a community pharmacy care integration project.
Nissen, L. M., Emerson, L. and Tett, S.E. (2001). Clinical pharmacy mentoring: Its role in a community pharmacy care integration project.. 25th Federal Conference of SHPA, Hobart, 8-11 November 2001. Hobart: Society of Hospital Pharmacists of Australia.
Taylor, P. J., Willis, C., Salm, P., Tett, S.E. and Pillans, P. (2001). Quantification of unbound mycophenolic acid by HPLC-atmospheric pressure chemical ionisation-tandem mass spectrometry. 18th Conference of the Australian & New Zealand Society for Mass Spectrometry, Gold Coast, Australia, 4-9 February 2001.
A review of the influences on prescribing: How does 'being bush' affect prescribing?
Cutts, C. and Tett, S. E. (2000). A review of the influences on prescribing: How does 'being bush' affect prescribing?. SHPA Biennial Clinical Conference, Gold Coast, 20-22 Oct. 2000. Australia: SHPA.
Tett, S. E., Roughead, E. E., Monteith, G. R. and Harvey, K. J. (2000). Australia's national medicines policy: Collating and evaluating the information from qummap.health.gov.au. SHPA Biennial Clinical Conference/Qld State Branch, Gold Coast, 20-22 Oct. 2000. Australia: SHPA.
Bayesian forecasting to predict tacrolimus concentrations in paediatric liver transplant recipients
Willis, C., Staatz, C., Lynch, S. V. and Tett, S. E. (2000). Bayesian forecasting to predict tacrolimus concentrations in paediatric liver transplant recipients. Annual Scientific Meeting of ASCEPT 2000, Newcastle, NSW, Australia, 3-6 December, 2000. Lilydale, Vic.: ASCEPT.
Coombes, I., Cottrell, N. and Tett, S. E. (2000). Clinical pharmacy advisor positions to support National Prescribing Service facilitators in Queensland. Melbourne, 10-12 Aug. 2000. Australia: NPS.
Coombes, I., Cottrell, N. and Tett, S. E. (2000). Clinical pharmacy advisor positions to support National Prescribing Service facilitators in Queensland. SHPA Biennial Clinical Conference/Qld State Branch, Gold Coast, 20-22 Oct.2000. Australia: SHPA.
Conjoint appointments - more than just hospital or community pharmacy?
Cutts, C., Tett, S. E. and Sheedy, V. (2000). Conjoint appointments - more than just hospital or community pharmacy?. APSA Annual Conference, Newcastle, 6-8 Dec. 2000. Brisbane: University of Qld.
Evaluating Australia's national medicines policy using geographical mapping: qummap.health.gov.au
Roughead, E. E., Tett, S. E., Monteith, G. R. and Harvey, K. J. (2000). Evaluating Australia's national medicines policy using geographical mapping: qummap.health.gov.au. 6th Pharmacy Australia Congress, Sydney, 27-30 Oct. 2000. Australia: PAC/FAPA.
Evaluation of an immunoassay to measure mycophenolic acid
Willis, C., Beal, J. L., Taylor, P. J. and Tett, S. E. (2000). Evaluation of an immunoassay to measure mycophenolic acid. TSANZ 18th Scientific Meeting 2000, Canberra, 12-14 April 2000. Australia: TSANZ.
Implementing a community pharmacy care integration project in rural and remote Queensland
Nissen, L. M., Kinsey, I., Volk, H., Britnall, S., Emerson, L. and Tett, S. E. (2000). Implementing a community pharmacy care integration project in rural and remote Queensland. APSA 2000 Annual Conference, Newcastle, 6-8 Dec. 2000. Brisbane: University of Queensland.
Bajramovic, J. and Tett, S. E. (2000). Improving quality use of medicines in multicultural Australia: Medication reviews in people from the former Yugoslavia. APSA 2000 Annual Conference, Newcastle, 6-8 Dec. 2000. Australia: The University of Queensland.
Investigation of the influences on the prescribing of rural and remote doctors
Cutts, C. and Tett, S. E. (2000). Investigation of the influences on the prescribing of rural and remote doctors. ASCEPT Annual Scientific Meeting, Newcastle, 3-6 Dec 2000. Australia: ASCEPT.
National medicines policy evaluation using qummap.health.gov.au
Overland, V., Roughead, E. E. and Tett, S. E. (2000). National medicines policy evaluation using qummap.health.gov.au. APSA 2000 Annual Conference, Newcastle, 6-8 Dec. 2000. Brisbane: University of Queensland.
Staatz, C. and Tett, S. E. (2000). Nonmen. Joint Meeting of ASCEPT and the British Pharmacological Society, Monash University, Melbourne, 25-28 April 2000. Australia: ASCEPT.
Rural Queensland's quality use of medicines project
Cutts, C., Sheedy, V. and Tett, S. E. (2000). Rural Queensland's quality use of medicines project. National Medicines Symposium 2000, Melbourne, 10-12 Aug 2000. Australia: NPS.
Rural relationships: Opportunities for clinical pharmacists
Cutts, C., Tett, S. E. and Sheedy, V. (2000). Rural relationships: Opportunities for clinical pharmacists. SHPA Biennial Clinical Conference/Qld State Branch Conference, Gold Coast, Qld, 20-22 Oct 2000. Australia: SHPA.
Six limited sampling models for the estimation of 12-hour mycophenolic acid auc.
Willis, C., Taylor, P. J., Salm, P., Rigby, R., Tett, S. E. and Pillans, P. (2000). Six limited sampling models for the estimation of 12-hour mycophenolic acid auc.. 18th Annual Scientific Meeting 2000, Canberra, 12-14 April 2000. Australia:
Nissen, L. M., Kinsey, I., Emerson, L. and Tett, S. E. (2000). Taking hospital experience into the community: Utilizing clinical pharmacy experience to implement a community pharmacy care integration project in rural and remote Queensland. SHPA Biennial Clinical Conference/Qld State Branch Conference, Gold Coast, 20-22 October 2001. Australia: SHPA.
Taylor, P. J., Rigby, R., Willis, C., Kubler, P., Salm, P., Tett, S. E. and Pillans, P. (2000). The relationship between mycophenolic acid concentration and clinical outcomes in renal allograft recipients. 18th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Canberra, 12-14 April, 2000. Australia: Transplantation Society of Australia and New Zealand.
Overland, V., Cottrell, N. and Tett, S.E. (2000). Use of angiotensin converting enzyme (ace) inhibitors after myocardial infarction: Drug use evaluation. ASCEPT Annual Scientific Meeting 2000, Newcastle, 3-6 Dec. 2000. Australia: ASCEPT.
Using the internet to evaluate national medicines policy : Aummap.health.gov.au
Tett, S. E., Overland, V., Roughead, E. E., Monteith, G. R. and Harvey, K. J. (2000). Using the internet to evaluate national medicines policy : Aummap.health.gov.au. Joint Meeting of ASCEPT and the British Pharmacological Society, Monash University, 25-28 April 2000. Australia: ASCEPT.
Utilising clinical pharmacy skills in rural and remote community pharmacies
Tett, S. E., Nissen, L., Kinsey, I., Volk, H., Britnall, S. and Emerson, L. (2000). Utilising clinical pharmacy skills in rural and remote community pharmacies. Pharmacy Australia Congress 2000, Sydney, 27-30 Oct 2000. Australia: PAC/FAPA.
An Australian PharmD: Doctor of Clinical Pharmacy. University of Queensland
Pulver, L. K. and Tett, S. E. (1999). An Australian PharmD: Doctor of Clinical Pharmacy. University of Queensland. SHPA Conference, Perth, Dec, 1999. Melbourne: Society of Hospital Pharmacists.
Evaluation of limited sampling strategies for the estimation of 12-hour Mycophenolic Acid
Willis, C., Taylor, P. J., Salm, P., Rigby, R., Tett, S. E. and Pillans, P. (1999). Evaluation of limited sampling strategies for the estimation of 12-hour Mycophenolic Acid. ASCEPT Conference, Sydney, Dec, 1999. Sydney: ASCEPT.
Factors that influence the pharmacokinetics of Tacrolimus in paediatric liver transplant recipients
Staatz, C., Lynch, S. V., Taylor, P. J., Willis, C. and Tett, S. E (1999). Factors that influence the pharmacokinetics of Tacrolimus in paediatric liver transplant recipients. ASCEPT Conference, Sydney, N.S.W., December, 1999. Sydney: ASCEPT.
Nissen, L. M., Smith, M. T., Tett, S. E., Williams, B. and Cramond, T. R. (1999). Opioid analgesic prescribing and use - An audit of analgesic prescribing by general practitioners and the Multidisciplinary Pain Centre at Royal Brisbane Hospital. Annual Scientific Meeting of the Australian Pain Society, Freemantle, W.A., 21-25 April 1999. Perth, Western Australia: Australian Pain Society.
Nissen, L. M., Smith, M. T., Tett, S. E., Williams, B. and Cramond, T. R. (1999). Opioid analgesic prescribing and use: An audit of analgesic prescribing by general practitioners and the Multidisciplinary Pain Centre at Royal Brisbane Hospital. Society of Hospital Pharmacists of Australia 24th Federal Conference, Perth, W.A., 25 - 28 November, 1999. Melbourne, Australia: Society of Hospital Pharmacists of Australia.
Nissen, L. M., Smith, M. T., Tett, S. E., Williams, B. and Cramond, T. R. (1999). Opioid analgesic prescribing and use: an audit of analgesic prescribing by general practitioners and the multidisciplinary Pain Centre at Royal Brisbane Hospital. Rationale, Resistance and Research. Royal Brisbane Hospital Health Care Symposium, Royal Brisbane Hospital, Brisbane, 21 - 27 October, 1999. Brisbane, Australia: Royal Brisbane Hospital Res. Foundation.
Population pharmacokinetics of lamotrigine
Chan, V., Morris, R. and Tett, S. E. (1999). Population pharmacokinetics of lamotrigine. ASCEPT Conf, Sydney, Dec 1999. Sydney: ASCEPT.
Staatz, C., Taylor, P. J., Lynch, S. V., Charles, B. G. and Tett, S.E (1999). Population pharmacokinetics of tacrolimus in Australian paediatric and adult liver transplant recipients. 6th International Congress of IATDMCT, Cairns, Qld, 13-17 September, 1999. New York: Lippincott-Raven.
QUMMAP.health.gov.au - evaluating Australia's national medicinal drug policy
Tett, S. E., Roughead, E. E., Monteith, G. R. and Harvey, K. J. (1999). QUMMAP.health.gov.au - evaluating Australia's national medicinal drug policy. ASCEPT Conf., Sydney, Dec 1999. Sydney: ASCEPT.
Quality use of medicines mapping project
Roughead, E. E., Tett, S. E., Monteith, G. R. and Harvey, K. J. (1999). Quality use of medicines mapping project. QUM Conference, Brisbane, 13-14 July 1999. Brisbane: Qld. Health.
Renal drug elimination - Fluconazole as part of a series of markers
Beal, J. L., Minns, I., McLachlan, A., Tett, S. E. and Gross, A. S. (1999). Renal drug elimination - Fluconazole as part of a series of markers. ASCEPT Conference, Sydney, Dec 1999. Sydney: ASCEPT.
Pillans, P., Willis, C., Kubler, P., Salm, P., Rigby, R., Tett, S. E and Taylor, P. J. (1999). The relationship between mycophenolic acid AUC and clinical outcomes in the first month post-renal transplant. 33rd Annual Scientific Meeting of ASCEPT, Darling Harbour, Sydney, 4-8 Dec, 1999. Sydney, Australia: Australian Society of Clinical & Experimental Pharmacology & Toxicology.
Validation of a series of markers for studying renal drug elimination
Tett, S. E., McLachlan, A., Minns, I., Beal, J. L. and Gross, A. S. (1999). Validation of a series of markers for studying renal drug elimination. Sixth International Congress Of Therapeutic Drug Monitoring And Clinical Toxicology, Cairns, Qld, 13-17 September, 1999. New York: Lippincott-Raven.
Evaluation of an immunoassay for mycophenolic acid in plasma compared with a HPLC-UV assay.
Tett, SE, Beal, JB, Jones, CE and Taylor, PJ (1998). Evaluation of an immunoassay for mycophenolic acid in plasma compared with a HPLC-UV assay.. WASHINGTON: AMER ASSOC CLINICAL CHEMISTRY.
Disposition and Absorption of Hydroxychloroquine Enantiomers Following a Single-Dose of the Racemate
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1994). Disposition and Absorption of Hydroxychloroquine Enantiomers Following a Single-Dose of the Racemate. 4th International Symposium on Chiral Discrimination, Montreal Canada, Sep 19-22, 1993. NEW YORK: WILEY-LISS. doi: 10.1002/chir.530060421
Tett, SE, McLachlan, AJ, Cutler, DJ and Day, RO (1994). Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine Enantiomers in Patients with Rheumatoid-Arthritis Receiving Multiple Doses of Racemate. 4th International Symposium on Chiral Discrimination, Montreal Canada, Sep 19-22, 1993. NEW YORK: WILEY-LISS. doi: 10.1002/chir.530060420
Insights From Pharmacokinetic and Pharmacodynamic Studies of Hydroxychloroquine
Tett, S, McLachlan, A, Day, R and Cutler, D (1993). Insights From Pharmacokinetic and Pharmacodynamic Studies of Hydroxychloroquine. 3rd World Conf On Variability in Response to Anti-Rheumatic Drugs, as a Satellite Meeting of the 5th World Conf of Clinical Pharmacology, Singapore Singapore, Jul 22-24, 1992. BASEL: BIRKHAUSER VERLAG.
Hydroxychloroquine Concentrations and Clinical Effects in Rheumatoid-Arthritis Patients
Tett, SE, Cutler, DJ and Day, RO (1990). Hydroxychloroquine Concentrations and Clinical Effects in Rheumatoid-Arthritis Patients. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/0014-2999(90)92892-M
Rural community pharmacists integrating care for people with complex health needs
Nissen, L. M. and Tett, S. E. (2005). Rural community pharmacists integrating care for people with complex health needs. Brisbane: Pharmacy Guild of Australia.
Nissen, L. M. and Tett, S.E. (2003). Community pharmacists providing clinical services for dispensing doctors and depot pharmacies in rural Queensland: Telepharmacy. Brisbane: The University of Queensland.
Nissen, L. M. and Tett, S. E. (2002). Pharmacists assisting general practitioners and the health care team in the integration of care for complex needs patients in rural and remote areas: Final report. Brisbane: The University of Queensland.
(2014–2015) Churches of Christ in Queensland
Designing optimal dosing regimens for immunosuppressant medications
(2014) Queensland Pharmacy Research Trust
Utilisation review of Ezetimibe
(2013–2014) Department of Health and Ageing
(2009–2013) Pharmacists Board of Queensland
(2009–2011) Department of Health and Ageing (Commonwealth of Australia)
(2009–2010) The JO and JR Wicking Trust
Uni of Southampton Evaluation of Nurse & Pharmacist Prescribing
(2009–2010) University of Southampton
Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs
(2008–2011) NHMRC Project Grant
(2008–2009) Department of Health and Ageing (Commonwealth of Australia)
Pilot study to include community pharmacies in distribution of prescription medicine starter packs
(2008) Pharmaceutical Society of Australia
(2007) Pharmaceutical Society of Australia
Maintenance and Promotion of the QUMMAP
(2006–2008) Department of Health and Ageing
Understanding and Improving Prescribing Practice
(2006–2008) National Prescribing Service Limited
Multicentre Drug Use Evaluation and other quality use of medicines activities in hospitals
(2005–2011) National Prescribing Service Limited
National Strategy for Quality Use of Medicines
(2004–2006) Department of Health and Ageing
NHMRC_Equipment Grant_HLTH_Pharmacy
(2004–2005) NHMRC Equipment Grant
Multi-centre drug use evaluation in hospitals
(2003–2005) National Prescribing Service Limited
Rural Community Pharmacists Integrating Care for People With Complex Health Needs
(2003–2005) Pharmacy Guild of Australia
Rural community pharmacists integrating care for people with complex health needs.
(2003–2005) Department of Health and Ageing
Pharmacokinetic and pharmacodynamic studies of the newer immunosuppressants
(2002–2005) NHMRC Project Grant
The Maintenance and promotion of the quality use of medicines mapping project website.
(2002–2003) Department of Health and Ageing
(2002) Pharmacy Guild of Australia
(2000–2001) National Prescribing Service Limited
Quality Use of Medicines Research
(2000–2001) Queensland Health
(1999–2001) Pharmacy Guild of Australia
Population pharmacokinetics, pharmacodynamics and dosage prediction for tacrolimus
(1999–2001) NHMRC Project Grant
The use of therapeutic flags to highlight potentially inappropriate prescribing in the elderley
(1999) National Prescribing Service Limited
Quality use of medication, pharmacokinetics, pharmacodynamics and optimal dose prediction
(1997–2000) NHMRC Project Grant
Fluconazole renal elimination processes in HIV infection and iatrogenic immunosuppression
(1996–1998) NHMRC Project Grant - HIV/AIDS (CARG)
Rational therapy of rheumatic disease with hydroxychloroquine
(1995–1996) Sterling Pharmaceuticals Pty Limited
(2009) Doctor Philosophy — Principal Advisor
Other advisors:
(2008) Doctor Philosophy — Principal Advisor
CONVENTIONAL MEDICINE AND COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) - CONCORDANCE AND PERSPECTIVES OF CONSUMERS, HEALTH PROFESSIONALS AND CAM PRACTITIONERS
(2007) Doctor Philosophy — Principal Advisor
Use of leflunomide in rheumatoid arthritis
(2005) Doctor Philosophy — Principal Advisor
Pharmacokinetic studies with sirolimus and tacrolimus
(2004) Doctor Philosophy — Principal Advisor
POPULATION PHARMACOKINETICS AND PHARMOCODYNAMICS OF THE NEW IMMUNOSUPRESSANT DRUGS
(2002) Doctor Philosophy — Principal Advisor
QUALITY USE OF MEDICINES: FROM DUE TO RURAL COMMUNITY PHARMACY PRACTICE
(2002) Doctor Philosophy — Principal Advisor
Other advisors:
(2021) Doctor Philosophy — Associate Advisor
Other advisors:
Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
(2016) Doctor Philosophy — Associate Advisor
Other advisors:
(2009) Doctor Philosophy — Associate Advisor
Other advisors:
Optimising the assesssment of renal function and determining the renal elimination of drugs using various methodologies
(2007) Doctor Philosophy — Associate Advisor
Note for students: The possible research projects listed on this page may not be comprehensive or up to date. Always feel free to contact the staff for more information, and also with your own research ideas.
Towards optimal dosing of new immunosuppressant drugs in solid organ transplants
Improving dosing of immunosuppressant medications in people who have received solid organ transplants. Studies with tacrolimus, mycophenolate or sirolimus can be offered
International comparisons of medicines use, investigating pharmaceutical policy and other influences on usage
International comparisons of the use of prescription medicines are important to improve the quality use of medicines across different jurisdictions. Lessons learned from one area can be translated into interventions to be applied to improve medicine use across a number of different health care systems
Factors affecting prescribing and use of medicines, including the influence of various marketing strategies (eg. free prescription medicine samples), the influence of location (eg. rural, remote) and
Many factors are know to affect prescribing and use of medicines. Projects in this area will be designed to investigate specific aspects of these factors eg. effects of remote location, influence of free sample medications etc etc
Drug usage evaluation across different jurisdictions
Drug usage evaluation, including the feedback, intervention and re-evaluation stages can influence how medicines are prescribed and used. Multicentre studies can have wide ranging influence, and studies across several jurisdictions (eg. hospital/community; public/private) can influence quality use of medicines in sustainable ways across large geographical areas. Projects are offered in the areas, particularly focussing on multi-disciplinary teams and multi-jurisdictional influences
Population Pharmacokinetics and Pharmacodynamics of the Newer Immunosuppressant Drug